Page last updated: 2024-08-23

bromocriptine and levodopa

bromocriptine has been researched along with levodopa in 622 studies

Research

Studies (622)

TimeframeStudies, this research(%)All Research%
pre-1990383 (61.58)18.7374
1990's140 (22.51)18.2507
2000's77 (12.38)29.6817
2010's19 (3.05)24.3611
2020's3 (0.48)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Quik, M; Sourkes, TL1
Winkelman, AC1
Goldfine, ID1
Frantz, AG; Kleinberg, DL1
Battista, AF; Fuxe, K; Goldstein, M; Lew, JY; Lieberman, A; Nakamura, S1
Hungerbühler, JP; Regli, F1
Rinne, UK9
Ringwald, E1
Estey, E; Goldstein, M; Goodgold, A; Gopinathan, G; Kupersmith, M; Lieberman, AN2
Przuntek, H1
Halbhübner, K; Herken, H; Loos, D1
Heuson, JC; Rozencweig, M1
Debono, AG; Donaldson, I; Marsden, CD; Parkes, JD1
Debono, AG; Marsden, CD; Parkes, JD2
Calne, DB; Gielen, AC; Gillespie, MM; Kartzinel, R; Perlow, M; Sadowsky, DA; TEYCHENNE, P1
Lipper, S1
Calne, DB; Neophytides, A; Nutt, JG; Plotkin, C; Teychenne, PF; Williams, AC1
Glaubman, H; Rabey, JM; Streifler, M; Vardi, J1
Lees, AJ; Shaw, KM; Stern, GM1
Lörincz, P; Ludin, HP; Ringwald, E1
Cowden, EA; Doyle, D; Macpherson, P; Ratcliffe, JG; Teasdale, GM; Thomson, JA1
Bannister, R1
Ahmann, PA; Ali, FM; Camp, VM; Caplan, DB; Faraj, BA; Newman, SL1
Kanatsuka, A; Kumagai, A; Makino, H; Matsushima, Y; Osegawa, M; Yamamoto, M1
Cowden, EA; Dobbie, JW; Kennedy, AC; Ratcliffe, JG; Ratcliffe, WA1
Hicks, PB; Samorajski, T; Smith, RC; Strong, JR1
Werner, S1
Avidan, S; Ayalon, D; Cordova, T; Harell, A; Jedwab, G; Persitz, E; Ravid, R1
Chamuleau, RA1
Cocchi, D; Locatelli, V; Müller, EE; Panerai, AE; Salerno, F1
Lander, CM; Lees, A; Stern, G1
Chiodini, PG; Cocchi, D; Lacatelli, V; Liuzzi, A; Mantegazza, P; Müller, EE; Oppizzi, G; Panerai, AE; Silvestrini, F1
Caine, E; Carter, AC; Ebert, M; Kartzinel, R1
Caraceni, T; Cocchi, D; Müller, EE; Panerai, AE; Parati, EA1
Battista, AF; Goldstein, M; Miyamoto, T1
Calne, DB; Kartzinel, R; Shoulson, I2
Carolei, A; Margotta, V; Palladini, G1
Battista, AF; Goldstein, M; Lew, JY; Lieberman, A; Matsumoto, Y1
Hill, JW1
Agnati, LF; Benfenati, F; Capelli, M; Cortelli, P; D'Alessandro, R; Galassi, E1
Hiestand, PC1
Dent, R; Guyda, H; Tolis, G1
Caine, ED; Davis, GC; Ebert, MH; Kopin, IJ; Markey, SP; Reichert, CM; Williams, AC1
Castegnaro, E; Pontiroli, AE; Pozza, G; Vettaro, MP; Viberti, GC1
Durand, JP; Gautier, JC1
Godwin-Austen, RB; Smith, NJ1
Gron, U1
Hansen, E; Kristensen, O1
Estey, E; Goldstein, M; Gopinathan, G; Kupersmith, M; Lieberman, A1
Frantz, AG1
Jansen, EN1
Agnoli, A; Casacchia, M; Ruggieri, S1
Pearce, I; Pearce, JM1
Bateman, DN; Coxon, A; Legg, NJ; Reid, JL1
Lance, JW; Mackenzie, RA2
Agid, Y; Barroche, G; Bonnet, AM; Javoy-Agid, F; Kato, G; Lhermitte, F; Pollak, P; Signoret, JL1
Parkes, D1
Dumas, M; Dumond, JJ; Garoux, R; Leger, JM; Lombertie, E1
Abu-fadil, S; Lachelin, GC; Yen, SS1
Carmina, E; Jannì, A; Lanzara, P; Lo Coco, R; Longo, RA1
Cei, S; Cosimato, F; Lombardi, G; Minozzi, M; Panza, N1
Marx, JL1
Clanet, M; David, J; Guiraud, B; Montastruc, JL; Rascol, A1
Albizzati, MG; Frattola, L; Scarlato, G; Trabucchi, M1
Barreca, T; Masturzo, P; Rolandi, E1
List, SJ; Seeman, P1
Bender, DA; Earl, CJ; Lees, AJ1
Brandi, AM; Bression, D; Cesselin, F; Mauborgne, A; Nousbaum, A; Peillon, F; Zygelman, N1
Glaubman, H; Rabey, J; Streifler, M; Vardi, J1
Allelov, M; Flechter, S; Hertzberg, M; Oberman, Z; Rabey, JM; Streifler, M; Vardi, J1
Lefebvre, J; Linquette, M; Loeuille, GA; Steinling, M1
Kellams, JJ; Lemberger, L; Rowe, H; Small, JG1
Klawans, HL; Nausieda, PA; Weiner, WJ1
Barrett, RE; Cote, LJ; Fahn, S; Isgreen, WP; Snider, SR1
Aloorkar, SD; Pandya, SK; Sheth, AR; Vaidya, RA1
Ben-David, M; Polishuk, WZ; Spitz, IM; Yarkoni, S1
Lachelin, GC; Leblanc, H; Yen, SS1
Fahn, S; Hutt, CS; Snider, SR1
Jotkowitz, S1
Delitala, G1
Caraceni, TA; Celano, I; Girotti, F; Parati, E1
Banovac, K; Petek, M; Sekso, M; Solter, M; Vizner, B1
Kanezuka, H; Makino, E; Matsushima, Y; Osegawa, M; Yamamoto, A1
Gragnoli, G; Martinelli, G; Pallassini, A; Signorini, AM; Tanganelli, I1
Gershon, S; Shopsin, B1
Barbeau, A; Bélanger, F; Butterworth, RF1
Johnels, B; Steg, G; Ungerstedt, U1
Bédard, P; Marsden, CD; Parkes, JD1
Bern, SM; Calne, DB; McInturff, D; Pfeiffer, RF; Teychenne, PF1
Haddad, S; Kohout, LJ; Lees, AJ; Shaw, KM; Stern, GM1
Jacobi, JM; Lloyd, HM1
Brandi, A; Cesselin, F; Mauborgne, A; Peillon, F; Zygelman, N1
Marttila, R; Rinne, UK1
Lees, A; Stern, G1
Barreca, T; Gallamini, A; Murialdo, G; Nizzo, MC; Polleri, A1
Yahr, MD1
Gilligan, B; Stark, R; Wodak, J1
Robyn, C1
Gerlach, J1
Kunz, F; Lörincz, P; Ludin, HP; Ringwald, E1
El'tsina, NV1
Perez-Lopez, FR1
Pohto, P1
Ward, HW1
Bartolini, A; Mantovani, P; Pepeu, G1
Bunney, WE1
Rabey, JM; Streifler, M; Vardy, J1
Marttila, R; Rinne, UK; Sonninen, V1
Calne, DB; Pfeiffer, RF; Teychenne, PF1
Johnson, AM; Loew, DM; Vigouret, JM1
Aono, T; Kohno, M; Kurachi, K; Shioji, T; Ueda, G1
Calne, DB; Kartznel, R1
McLellan, DL1
Estey, E; Goldstein, M; Kupersmith, M; Lieberman, A1
Alagna, S; Delitala, G; Devilla, L; Lotti, G; Masala, A1
Dickey, RP; Stone, SC1
Bassendine, MF; Calne, DB; Claveria, LE; Petrie, A; Teychenne, PF1
Camanni, F; Isaia, GC; Massara, F; Molinatti, GM1
Alagna, S; Delitala, G; Devilla, L; Masala, A1
Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE1
Reid, WG1
Kamal, TJ; Molitch, ME1
Alves, RS; Barbosa, ER; Scaff, M1
Lieberman, A2
Mizuno, Y1
Goto, I; Iwata, M; Kanazawa, I; Kowa, H; Mannen, T; Mizuno, Y; Nakanishi, T; Nishitani, H; Ogawa, N; Takahashi, A6
Kraus, PH; Letzel, H; Przuntek, H; Schwarzmann, D; Welzel, D1
Blümner, E; Danielczyk, W; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Schwarzmann, D; Welzel, D; Wolf, H1
Andersson, U; Aquilonius, SM; Freccero-Rosman, K; Lindvall, O; Nylander, B; Odin, P1
Albani, F; Baruzzi, A; Contin, M; Martinelli, P; Riva, R1
Levivier, M; Przedborski, S1
Laihinen, A; Rinne, UK; Suchy, I1
Cooper, JA; Doherty, SM; Jordan, N; Sagar, HJ; Sullivan, EV; Tidswell, P1
Haas, JA; Jansen, EN; Lakke, JP; Staal-Schreinemachers, A; van der Sande, JJ1
Durrieu, G; LLau, ME; Montastruc, JL; Rascol, A; Rascol, O; Senard, JM1
Graff, E; Korczyn, AD; Rabey, JM; Shabtai, H; Vered, Y1
Suitsu, N1
Cooper, JA; Jordan, N; Sagar, HJ1
Ahlskog, JE; Carmichael, SW; Kelly, PJ; Nelson, A; Okazaki, H; Richelson, E; Stoddard, SL; Tyce, GM; van Heerden, JA1
Allain, H; Bentue-Ferrer, D; Decombe, R; Lemaitre, MH; Martinet, JP; Milon, D1
Morgan, MY1
Fujishima, M; Ikenoue, H; Kuroda, T; Okamura, K; Sato, K; Tokuyama, T; Yoshinari, M1
Chokroverty, S; Hening, WA; Walters, AS1
Cramer, H; Kuntzmann, F; Masson, H; Popescu, I; Strubel, D1
Allain, H; Bentue-Ferrer, D; Brunet-Bourgin, F; Chaumet-Riffaud, P; Decombe, R; Gandon, JM; Goulley, F; Le Coz, F; Loria, Y; Reymann, JM1
Graff, E; Harsat, A; Rabey, JM; Schwartz, M; Vered, Y1
Nakashima, K; Takahashi, K1
Chariá, P; Díaz, F; Liberman, C1
Onodera, K; Shinoda, H1
Jacobs, MB; Varon, J1
Goto, I; Harada, M; Kira, J; Shida, N; Yamaguchi, Y1
Eriksson, T; Oberg, B; Pedersen, SW1
Davis, A; Jenner, P; Marsden, CD1
Haba, K; Mizukawa, K; Ogawa, N; Sato, H1
Bédard, PJ; Di Paolo, T; Gagnon, C1
Kempi, V; von Scheele, C1
Kleedorfer, B; Poewe, W; Schelosky, L1
Durrieu, G; Montastruc, JL; Rascol, A; Senard, JM; Tran, MA1
MacMahon, DG; Marshall, T; Overstall, PW1
Edwards, RL; Oliver, WA; Todman, DH1
Montastruc, JL; Rascol, A; Rascol, O3
Cowan, A1
Arvat, E; Bellone, J; Camanni, F; Ghigo, E; Imperiale, E; Mazza, E; Procopio, M1
Olsson, JE1
Becker, AL; Bilchik, TR; Blumenfeld, A; Fourie, PB; Fritz, VU; Ming, A; Reef, HE; Saling, M; Temlett, JA1
Bédard, PJ; Di Paolo, T; Rouillard, C1
Bakheit, AM; Henderson, LM; Moore, AP; Simpson, JA; Thomas, M1
Dufresne, JJ1
Bar, M; Graff, E; Isakov, M; Oberman, Z; Rabey, JM; Scharf, M1
Bédard, P; Boucher, R; Daigle, M; Di Paolo, T1
Albani, G; Amabile, G; Fattapposta, F; Morocutti, C; Pozzessere, G; Rizzo, PA; Sanarelli, L1
Calne, DB; Calne, S; Douglas, J; Postnikoff, D; Poulin, K; Ross, S; Tsui, JK; Woodward, W1
Pidgeon, JF; Wolf, MA1
Bartholomew, M; Boucher, AE; Demers, LM; Harvey, HA; Lipton, A; Manni, A; Simmonds, MA1
Bar, M; Graff, E; Isakov, A; Oberman, Z; Rabey, JM; Scharf, M1
Broe, GA; Genge, S; Hely, MA; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM2
Selby, G1
Glatt, S; Hassanein, R; Koller, WC; Vetere-Overfield, B1
Benabid, AL; Champay, AS; Hommel, M; Perret, JE; Pollak, P1
Ackermann, H; Oertel, WH; Ziegler, W1
Villares, JC1
Calne, D; Hertzman, C; Snow, B; Wiens, M1
Beart, PM; Cook, CJ; Hashizume, M; Jackson, DM; Tabar, J1
Goldberg, LI; Rajfer, SI1
Becker, RE; Blitzer, RD1
Casey, DE1
Chiodini, PG; Dallabonzana, D; Liuzzi, A; Oppizzi, G; Verde, GG1
Dichgans, J; Scholz, E1
Harvey, NS1
Minagawa, F; Nakabayashi, H; Takeda, R1
Aono, T; Hidaka, H; Iwase, K; Masunaga, R; Nagasaka, A; Nakagawa, H; Nakai, A; Ohyama, T1
Jenner, P; Marsden, CD1
Huber, M1
Boyce, S; Jenner, P; Marsden, CD1
Cummings, JL; Friedenberg, DL1
Bratton, M; Jost, MG; Lannon, MC; Lockhart-Pretti, P; Thomas, CA1
Facchinetti, F; Genazzani, AR; Golinelli, S; Oltramari, P; Petraglia, F; Santoro, V; Volpe, A1
Pugsley, TA; Stewart, SF1
Berlan, M; Boneu, B; Caranobe, C; Lafontan, M; Montastruc, JL; Rascol, A; Villeneuve, A1
Cella, SG; Lampis, A; Locatelli, V; Loche, S; Müller, EE; Pintor, C1
Herskovits, E; Leston, J; Yorio, A1
Hassing, JM; Huseman, CA; Sibilia, MG1
Laihinen, A; Rinne, UK1
LeWitt, PA1
Mondal, BK; Mondal, KN1
Birkmayer, JD; Birkmayer, W1
Jansen, EN; Meerwaldt, JD1
Aminoff, MJ1
Huang, KE; McDonald, JV; Muechler, EK; Tang, L1
Perić, LA; Prelević, GM; Würzburger, MI1
Dash, RJ; Rao, NS; Sialy, R; Sriprakash, ML1
Fujita, M; Shimizu, T1
Dubuis, R1
Birkmayer, W1
Braz, S; Ferreira, TM; Silveira Filho, NG; Troncone, LR; Tufik, S1
Calne, DB; Rinne, UK1
Holland, OB; Kennedy, B; Lake, CR; Murphy, D; Ziegler, MG1
Boyadjieva, M; Ovtcharov, R; Zaharieva, B1
Hashimoto, T; Koda, H; Kuriyama, K1
Hanew, K; Mizuno, Y; Sakuma, H; Takase, S; Teramura, K1
Bouchard, S; Gawel, MJ; King, DB; Libman, I; McLean, DR; Paulseth, R; Raphy, B; Riopelle, RJ1
Wallis, WE2
Bouchard, S; Gawel, MJ; Libman, I; Riopelle, RJ1
Allain, H; Bentué-Ferrer, D; Reymann, JM; Sabouraud, O; Van den Driessche, J1
Perquin, WV; Van Leeuwen, RB1
Wermuth, L1
Larsen, JP; Nessler, EG; Strandjord, R1
Berman, ML; Tennant, F1
Lyman, CP; O'Brien, RC1
Bédard, PJ; Dipaolo, T; Falardeau, P; Rouillard, C1
Kurahashi, K; Matsunaga, M; Narita, S; Tanaka, T; Watahiki, Y1
Geber, J; Gjuris, V; Krizanac, S; Mise, S; Petek, M; Rotkvić, I; Sikirić, P; Suchanek, E; Tućan-Foretić, M; Udovicić, I1
Gollomp, SM; Hurtig, HI; Stern, MB; Vernon, GM1
Bédard, PJ; Boucher, R; Di Paolo, T; Falardeau, P1
Williams, A1
Robertson, GS; Robertson, HA1
Agniel, A; Celsis, P; Demonet, JF; Doyon, B; Marc-Vergnes, JP; Montastruc, JL; Puel, M; Rascol, A1
Kato, K; Seki, K; Shima, K1
Akpinar, S1
Bouchard, S; Gawel, M; Libman, I; Riopelle, R1
Lindvall, B; Olsson, JE1
Lakke, JP; Staal-Schreinemachers, AL1
Aso, K; Furune, S; Negoro, T; Nomura, K; Takahashi, I; Watanabe, K; Yamamoto, N1
Sandyk, R2
Gibson, JM; Kennard, C; Pimlott, R1
Riopelle, RJ1
Bouchard, S1
Lazarus, A1
Kadykov, AS; Pivovarova, VM; Shvedkov, VV; Stoliarova, LG1
Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF1
Muenter, MD2
Klawans, HL; Paleologos, N1
Lakke, JP; Staal-Schreinemachers, AL; Wesseling, H1
Barkemeyer, CA; Hawkins, MF; Tulley, RT1
Palmieri, V; Tardi, S; Ventrella, F1
Draper, IT1
Wilson, JA1
Calne, DB; Glover, R; Lau, E; Schulzer, M; Waterman, K1
Boyce, S; De Ceballos, ML; Jenner, P; Marsden, CD1
Goh, M; Hanew, K; Sasaki, A; Sato, S; Yoshinaga, K1
Flechter, S; Graff, E; Oberman, Z; Rabey, JM; Vardi, J2
Cvitanović, B; Geber, J; Gjuris, V; Ivanović, D; Mise, S; Rotkvić, I; Sikirić, P; Suchanek, E; Tućan-Foretić, M1
Johnels, B1
van der Drift, JH1
de Pedro, J; Rosenqvist, U1
Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A1
Jonsson, G; Mefford, I; Schultz, W; Studer, A; Sundström, E1
Jackson, DM; Jenkins, OF1
Jankovic, J1
Hardie, RJ; Lees, AJ; Stern, GM1
Goldstein, M; Lieberman, AN1
Bruggendieck, B; Campino, C; Generini, G; Michelsen, H; Piraino, P; Pumarino, H1
Feldman, RG; Lannon, MC1
Huseman, CA1
Boiadzhieva, N; Ovcharov, R; Zakharieva, B1
Wirz, D1
Hirooka, M; Itoh, M; Nagasaka, A; Nakagawa, H; Nakagawa, K; Nakai, A; Nihei, N; Ohyama, T; Sugiura, T; Yabe, Y1
Hietala, J; Koulu, M; Scheinin, M; Syvälahti, E1
Bowser, EN; Hargis, GK; Kukreja, SC; Sethi, R; Williams, GA1
Agid, Y; Dubois, B1
Elton, RL; Hoehn, MM1
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G1
Delgado, MR; Grimes, JD1
Kapfhammer, HP; Rüther, E1
Hoehn, MM2
Ando, K; Mano, Y; Satoyoshi, E; Sunohara, N1
Glantz, RH; Goetz, CG; Klawans, HL; Tanner, CM1
Baas, H; Fischer, PA; Japp, G; Schneider, E2
Indo, T1
Su, YH1
Aleksić, J; Geber, J; Gjuris, V; Ivanović, D; Marović, A; Reić, P; Sikirić, P; Suchanek, E1
Grau-Veciana, JM; Peiró Grasa, A1
Morris, JG3
Schott, GD1
Hershey, LA1
Luquin, MR; Martínez Lage, JM; Obeso, JA1
Bamji, AN; Calne, DB; Greenacre, JK; Leigh, PN; Teychenne, PF1
Assies, J; Schellekens, AP; Touber, JL1
Burton, K; Calne, DB1
Calne, DB; Plotkin, CN; Rosin, AJ; Teychenne, PF1
Goldfine, ID; Vigneri, R1
Frohman, LA; Maeda, K1
Lees, AJ; Stern, GM2
Misra, P1
Hallett, M1
Andreeva, OG; Korovin, KF; Ostroumova, MN; Schelkunov, EL1
Ross, ED; Stewart, RM1
Enna, SJ; Lake, CR; Teychenné, PF; Ziegler, MG1
Larsen, TA; Teräväinen, H1
Weiner, M1
Hoyumpa, AM; Schenker, S1
Altilia, F; Amadio, R; Cipollini, F1
Ishibashi, M; Yamaji, T1
West, AP1
Marchesini, G; Pisi, E1
Goldberg, LI1
Kurako, IuL; Volianskiĭ, VE1
Jellinger, K1
Fischer, PA; Schneider, E1
Jörg, J1
Biesemeyer, H; Ludin, HP; Ringwald, E1
Beckman, J; Burton, K; Calne, DB; Martin, WR1
Laakso, K; Laihinen, A; Lönnberg, P; Rinne, JK; Rinne, JO; Rinne, UK1
Globus, M; Melamed, E1
Calne, DB; Dambrosia, JM; Foster, N; Larsen, TA; LeWitt, PA; Newman, RP; Raphaelson, MI; Ward, CD1
Crossley, IR; Williams, R1
Fischer, PA; Majer, M; Przuntek, H; Welzel, D1
Barontini, M; Bazán, MC; Bergadá, C; Domené, H; Heinrich, JJ1
Avidan, S; Ayalon, D; Caufriez, A; Eckstein, N; Eshel, A; L'Hermite, M; Spitz, I; Zylber-Haran, E1
Hassing, JM; Huseman, CA1
Bihari, K; Csanda, E; Köves, A; Mogyorós, I; Takáts, A; Tárczy, M1
Koulu, M; Lammintausta, R1
Alonso, RJ; Covington, TR; Mancall, EL1
Deupree, JD; Murrin, LC; Pfeiffer, RF; Schneider, MB1
Da Prada, M; Haefely, WE; Keller, HH; Kettler, R; Pieri, L1
Armstrong, D; Courtney, CL; Palfai, T1
Ambrosoli, C; Armocida, G; Finavera, L; Majeron, MA; Quisi, Q1
Destée, A; Fossati, P; Petit, H; Warot, P1
Bouchard, S; Grimes, JD; King, DB; Kofman, OS; Molina-Negro, P; Wilson, AF1
Ackman, D; Etienne, P; Kiely, ME; Lal, S; Thavundayil, JX1
Calne, DB; Larsen, TA; LeWitt, P; Newman, R1
Fischer, PA; Hubener, K; Schneider, E2
Schiffter, R; Vogel, HP1
Caraceni, T; Carella, F; Giovannini, P; Grassi, MP; Parati, E; Scigliano, G1
Lipcsey, A; Peres, A1
Goldstein, M; Gopinathan, G; Hassouri, H; Lieberman, AN; Neophytides, A1
Calne, DB; Newman, RP1
Brincat, S; Lang, AE; Marsden, CD; Parkes, JD; Quinn, N1
Bear, G; Casson, I; Durso, R; Foo, SH; Goldstein, M; Khayali, M; Kupersmith, M; Lieberman, A; Neophytides, A1
Anile, C; Barbarino, A; De Marinis, L; Maira, G1
Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S1
Allain, H; Bentue-Ferrer, D; Pape, D; Reymann, JM; Sabouraud, O; van den Driessche, J1
Brismar, K1
Chang, CC; Chang, TC; Chen, FW; Huang, TS1
Calne, DB; Eisler, T; Kaiser, DL; MacLeod, RM; Thorner, MO1
Bannet, J; Belmaker, RH; Globus, M; Lerer, B1
Gopinathan, G; Hiesiger, E; Leibowitz, M; Lieberman, AN; Neophytides, A; Walker, R1
Goldstein, M; Goodgold, A; Gopinathan, G; Leibowitz, M; Lieberman, AN; Neophytides, A; Pact, V; Walker, R1
Delwaide, PJ; Schoenen, J1
McDevitt, JT; Setler, PE1
Hammond, CB; Vaughn, TC1
Agnati, LF; Fuxe, K1
Calne, DB; Teräväinen, H1
Calne, DB; Le Witt, PA1
Glantz, R; Goetz, CG; Klawans, HL; Nausieda, PA; Weiner, WJ1
Gnatyshak, AI1
Adam, WR; Campbell, DJ; Funder, JW; Mendelsohn, FA1
Goetz, CG; Nausieda, PA; Tanner, CM1
Haas, JA; Lakke, JP1
Iimura, O; Nakagawa, M; Shimamoto, K1
Bauman, JE; Masters, WH; Schwartz, MF1
Klawans, HL1
Gauthier, G; Martins da Silva, A1
Kaplan, LR; Klawans, HL; Nausieda, PA; Weber, S; Weiner, WJ1
Cunningham, JR; Duchesneau, PM; Gidwani, GP; Gupta, MS; Schumacher, OP1
Agid, Y; Illas, A; Lhermitte, F; Quinn, N1
Bergsrud, D; Elton, RL; Racy, A; Teychenne, PF; Vern, B1
Lieberman, AN; Plasse, HM1
Ulm, G1
Grimes, JD; Hassan, MN1
Agid, Y; Lhermitte, F; Quinn, N1
Stewart, RM1
Fang, VS1
Malarkey, WB; Tallo, D1
Bøttcher, J; Grøn, U1
Angelini, L; Broggi, G; Mainini, P; Moretti, G; Nardocci, N1
Caraceni, T; Giovannini, P; Girotti, F; Parati, E; Pederzoli, M; Scigliano, G1
Danielczyk, W1
Alberetto, M; De Castro e Silva, E; De Pasqua, A; Girardi, AM; Pellicciotta, G; Pontiroli, AE; Pozza, G1
Casson, I; Durso, R; Foo, SH; Goldstein, M; Gopinathan, G; Khayali, M; Kupersmith, M; Lieberman, AN; Neophytides, A; Tartaro, T1
Barrett, RE; Côté, LJ; Fahn, S; Snider, SR1
Godwin-Austen, RB1
Lander, CM; Lees, AJ; Shaw, KM; Stern, GM1
Duvoisin, RC; Mendoza, MM; Yahr, MD1
Bédard, P; Debono, AG; Dorow, R; Horowski, R; Jenner, P; Keenan, J; Marsden, CD; Parkes, JD; Price, P; Rosenthaler, J; Schachter, M; Smith, B1
Biller, B; Feldman, ZT; Gagel, RF; Graze, K; Kapcala, LP; Reichlin, S; Spiler, IJ; Tashjian, AH1
Bertha, G; Lechner, H; Ott, E1
Marsden, CD; Parkes, JD; Schachter, M; Sheehy, MP1
Bushenbark, K; Esterlitz, J; Gauger, L; Hauser, RA; Hubble, J; Koller, W; Lilienfeld, D; Malapira, T; Olanow, CW1
Eadie, MJ1
Ludin, HP1
Clinnick, S; Fonda, D; Schwarz, J1
Janjua, R; Roos, RA; van Kempen, GM1
Modigliani, E1
Danysz, W; Quack, G; Rogoz, Z; Skuza, G1
Angeleri, V; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G1
Mark, MH; Sage, JI1
Asanuma, M; Kawai, M; Kohno, M; Masumizu, T; Mori, A; Ogawa, N; Tanaka, K1
Ogawa, N1
Goto, I; Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N3
Hineno, T; Horiguchi, J; Kakimoto, Y; Mizobuchi, M; Nishimatsu, O1
Eberli, F; Greminger, P; Schmid, PA; Speich, R; Suter, T1
Angeleri, VA; Bonuccelli, U; Cossutta, E; De Mari, M; Foschi, N; Lamberti, P; Martignoni, E; Muratorio, A; Pacchetti, C; Pezzoli, G1
Ané, M; Blin, O; Fabre, N; Montastruc, JL; Poulik, J; Rascol, A; Rascol, O; Sabatini, U; Senard, JM1
Broe, GA; Hely, MA; Margrie, S; Morris, JG; O'Sullivan, DJ; Rail, D; Reid, WG; Williamson, PM1
Montastruc, JL; Rascol, A; Rascol, O; Senard, JM1
Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK1
Yanagisawa, N2
Dichgans, J; Klockgether, T1
Lang, AE; Mark, MH; Sage, JI; Zimmerman, TR1
Lauterbach, EC1
Cooper, JA; Sagar, HJ; Sullivan, EV1
Comella, CL; Ristanovic, RK; Tanner, CM1
Klockgether, T; Löschmann, PA; Schugens, MM1
Rumbach, L; Tranchant, C; Viel, JF; Warter, JM1
Factor, SA; Weiner, WJ1
Kuno, S2
Chanter, DO1
Kornhuber, J; Weller, M1
Cornelius, L; Factor, SA; Ingenito, A; Sanchez-Ramos, JR; Sheldon, C; Singer, C; Weiner, WJ1
Duchek, M; Ekberg, R; Fehling, C; Johansson, F; Johnels, B; Lindvall, B; Nordin, G; Olsson, JE; Sidén, A; Steg, G1
Hadjiconstantinou, M; Hubble, JP; Neff, NH; Sylvia, CP; Wemlinger, TA1
Abercrombie, ED; DeBoer, P; Heeringa, M; Westerink, BH1
Amiel, C; Comoy, E; Couette, S; Friedlander, G; Garcia-Ocaña, A; Perrichot, R1
Falk, M; Künig, G; Neubauer, M; Ransmayr, G; Wagner, M1
Agid, Y; Bonnet, AM; Dubois, B; Marconi, R; Serre, I1
Lees, AJ1
Emrich, D; Hajak, G; Kögler, A; Munz, DL; Riemann, H; Rüther, E; Staedt, J; Stoppe, G1
Akiyama, K; Ishihara, T; Kashihara, K; Shiro, Y; Shohmori, T1
Ahlskog, JE1
Kishore, A; Snow, BJ1
Benabid, AL; Benazzouz, A; Hoffmann, D; Limousin, P; Perret, JE; Pollak, P1
Akiyama, K; Ishihara, T; Kashihara, K; Kuroda, S; Morimasa, T; Shomori, T1
Akiguchi, I; Fukuyama, H; Imai, T; Kawamura, J; Kimura, J1
Dierks, T; Grosse, H; Kuhn, W; Müller, T; Rommelspacher, H1
Adena, MA; Broe, GA; Hely, MA; Morris, JG; O'Sullivan, DJ; Reid, WG; Williamson, PM1
Blümner, E; Danielczyk, W; Gerlach, M; Kaiser, HJ; Kraus, PH; Letzel, H; Przuntek, H; Riederer, P; Uberla, K; Welzel, D1
Fukuda, T; Tanaka, J; Watabe, K1
de Saint-Martin, A; Hirsch, E; Marescaux, C; Picard, F; Salmon, E1
Montastruc, JL; Rascol, O; Senard, JM2
del Toro Cervera, J; García Castaño, J; Muiño Miguez, A; Segado Soriano, A1
Berlot, G; Cociancich, N; Gullo, A; Tomasini, A; Viviani, M1
Burguera, JA; Chacón, J; Forcadell, F; Giménez-Roldán, S; Liaño, H; Tolosa, E1
Fukuzaki, K; Kitahara, K; Kohno, Y; Koja, T1
Mizuno, Y; Yanagisawa, N1
Agid, Y; Destée, A; Durif, F; Montastruc, JL; Pollak, P1
Giménez-Roldán, S; Mateo, D1
de Yébenes, JG; García-Ruiz, PJ; Sánchez-Pernaute, R1
Kanazawa, I; Kowa, H; Kuno, S; Mizuno, Y; Ogawa, N; Tashiro, K; Yanagisawa, N1
McCallum, RW; Sarosiek, I; Shifflett, J; Soykan, I; Wooten, GF1
Araki, T; Itoyama, Y; Kobayashi, T; Ohta, T; Oshima, Y; Takeshita, M1
Baudewig, J; Bruns, D; Paulus, W; Tergau, F; Ziemann, U1
Marsden, CD1
Banerji, T; Jenner, P; Marsden, CD; Pearce, RK1
Abrams, KR1
Ben-Shlomo, Y; Churchyard, A; Head, J; Hurwitz, B; Lees, AJ; Ockelford, J; Overstall, P1
Brotchie, JM; Crossman, AR; Henry, B2
Amano, K; Takakura, K1
Haida, M; Kozuma, R; Shinohara, Y; Takagi, S; Takahashi, W; Yoshii, F1
Adair, JC; Davis, LE1
Brunt, ER; Korczyn, AD; Larsen, JP; Nagy, Z; Poewe, WH; Ruggieri, S1
Sunohara, N1
Freed, WJ; Kishikawa, M; Takashima, H; Tsujihata, M1
Weiner, WJ1
Chuda, M; Hayabara, T; Ihara, Y; Kuroda, S1
Finken, MJ; Ramaker, C; van de Beek, WJ; van Hilten, BJ1
Clarke C, E; Speller J, M1
Finken, MJ; Ramaker, C; Van de Beek, WJ; van Hilten, JJ1
Clarke, CE; Speller, JM1
Busenbark, K; Hauser, RA; Hubble, JP; Koller, WC; Malapira, T; Olanow, CW1
Hirschelmann, R; Thong, NT1
Clarke, CE; Deane, KH2
Ramaker, C; van Hilten, JJ1
Clarke C, E; Clarke J, A; Speller J, M1
Asanuma, M; Ogawa, N; Tanaka, K1
Milkov, V; Miteva, K; Pironcheva, G; Russev, G; Zlatarev, S1
Hasegawa, K1
Fukuzaki, K; Kamenosono, T; Kitazumi, K; Nagata, R1
Haapaniemi, TH; Kallio, MA; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U1
Sternon, J; Supiot, F; Zegers de Beyl, D1
Clarke, CE; Deane, KD1
Haapaniemi, TH; Korpelainen, JT; Myllylä, VV; Sotaniemi, KA; Suominen, K; Tolonen, U1
Chew, EL; Ong, KC; Ong, YY1
Brefel-Courbon, C; Desboeuf, K; Lapeyre-Mestre, M; Montastruc, JL; Rascol, O; Senard, JM1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A1
Susman, VL1
Bamias, C; Hardy, P; Pocock, S; Warner, J; White, IR1
Andersson, M; Cenci, MA; Lundblad, M; Westin, JE1
Ben-Shlomo, Y; Head, J; Katzenschlager, R; Lees, AJ1
Hillman, R; Parvez, F; Pendleton, RG; Sayed, M1
Andersson, M; Cenci, MA; Kirik, D; Lundblad, M; Wierup, N; Winkler, C1
Brooks, DJ; Brunt, ER; Korczyn, AD; Montastruc, JL; Stocchi, F1
Keens, J; Schrag, A; Warner, J1
Bittkau, S; Bliesath, H; Büttner, U; Fuchs, G; Glass, J; Haller, H; Klockgether, T; Kraus, P; Lachenmayer, L; Müller, D; Müller, T; Przuntek, H; Rathay, B; Sgonina, J; Steinijans, V; Teshmar, E; Ulm, G; Volc, D1
Hilten, JJ; Ramaker, C1
Bar-Gad, I; Bergman, H; Goldberg, JA; Heimer, G1
Hauser, RA; Holford, NH1
Kondo, T1
Cannizzaro, C; Jenner, P; Pearce, RK; Rose, S; Tel, BC; Zeng, BY1
Reingardiene, D1
Cho, IS; Ha, JH; Im, JH; Lee, MC1
Quinn, NP1
Debette, S; Kozlowski, O; Rousseaux, M; Steinling, M1
Lai, BC; Marion, S; Schulzer, M; Teschke, K; Tsui, JK1
Beier, KM; Berger, Ch; Mehrhoff, FW; Meinck, HM1
Blackman, JA; Buck, ML; Conaway, MR; Patrick, PD1
Bagheri, H; Montastruc, JL; Schmitt, L1
Okamoto, K; Tanaka, M1
Allain, H; Colin, F; Flet, L; Polard, E; Trioux, E1
Kameyama, M; Kubori, T; Matsui, H; Nishinaka, K; Oda, M; Udaka, F1
Gispen-de Wied, CC; Kahn, RS; Kemner, C; Oranje, B; Verbaten, MN; Westenberg, HG2
Grosset, D; Grosset, K; Macphee, G; Needleman, F1
Clarke, CE; Deane, KH; Spieker, S1
Hely, MA; Morris, JG; Reid, WG; Trafficante, R1
Hoffmann, A; Klotz, P; Kraus, PH; Lewe, J; Przuntek, H1
Jost, WH1
Mitsumoto, Y; Mori, A; Moriizumi, T; Nakai, M; Ohashi, S1
Chen, WH; Liu, JS; Lu, YC; Lui, CC1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C1
Elovic, EP; Napolitano, E; Qureshi, AI1
Azouvi, P; Ben Smaïl, D; Régnault, J; Rouy-Thenaisy, K; Samuel, C1
Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G1
Chan, PL; Holford, NH; Kieburtz, K; Nutt, JG; Shoulson, I1
Turnbull, GI1
Cenci, MA; Lindgren, HS; Lundblad, M; Ohlin, KE; Rylander, D1
Colau, JC; Ha, DE; Legendre, G1
Lindh, J1
Ives, NJ; Ramaker, CC; Stowe, R; van Hilten, JJ2
Ben-Shlomo, Y; Evans, A; Head, J; Katzenschlager, R; Lees, AJ; Schrag, A1
Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S1
Marín, E; Uribe, M1
Montgomery, EB1
Cenci, MA; Lindgren, HS; Ohlin, KE1
Awa, Y; Hattori, T; Higuchi, Y; Ichikawa, T; Ito, T; Kobayashi, M; Kuwabara, S; Sakakibara, R; Uchiyama, T; Yamaguchi, C; Yamamoto, T; Yamanishi, T; Yanagisawa, M; Yano, M1
Aubut, JA; Bayley, M; Foley, N; Marshall, S; Megyesi, J; Meyer, MJ; Meythaler, J; Murie-Fernandez, M; Salter, K; Teasell, R1
Bormans, G; Bosier, B; Casteels, C; Lambert, DM; Van Laere, K; Vanbilloen, B; Vercammen, D1
Dunnett, SB; Lane, EL1
Schneemilch, C1
Halliday, GM; Hely, MA; Loy, C; Morris, JG; Reid, WG1
Auyeung, M; Cheung, CM; Lee, CN; Li, R; Tang, WK; Tsoi, TH; Yeung, E1
Amato, L; Davoli, M; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P1
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H1
Nakagawasai, O; Nemoto, W; Sato, S; Tadano, T; Tan-no, K; Taniguchi, R; Yamadera, F; Yaoita, F1
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ1
Hisanaga, R; Nakamura, M; Nomoto, S; Sato, T1
Als-Nielsen, B; Gluud, C; Gluud, LL; Junker, AE1
Macedo, CR; Macedo, EC; Prado, GF; Silva, AB; Torloni, MR1
Goyal, RK; Jhala, MK; Joshi, CG; Patel, AK; Rana, DG1
Amato, L; Davoli, M; De Crescenzo, F; Minozzi, S; Pani, PP; Solimini, R; Vecchi, S; Zuccaro, P1
Broderick, PA; Li, YS; Wenning, L1
Ji, F; Jiang, R; Su, Z; Xue, R; Zhou, Y; Zhu, X; Zhuo, C1
Aslanoglou, D; Benner, V; Farino, ZJ; Freyberg, Z; Lopez-Valencia, M; McCarthy, MJ; Osborn, O; Wei, H; Zapata, RC1
Huang, X; Mailman, RB; Yang, Y1
Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C1

Reviews

90 review(s) available for bromocriptine and levodopa

ArticleYear
Medical treatment of acromegaly.
    Annual review of medicine, 1978, Volume: 29

    Topics: Acromegaly; Adrenergic alpha-Agonists; Bromocriptine; Estrogens; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Medroxyprogesterone; Serotonin Antagonists; Somatostatin

1978
[Considerations in the drug treatment of parkinsonism (author's transl)].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1978, Nov-07, Volume: 67, Issue:45

    Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor

1978
Recent advances in research on Parkinsonism.
    Acta neurologica Scandinavica. Supplementum, 1978, Volume: 67

    Topics: Acetylcholinesterase; Adult; Apomorphine; Benserazide; Brain; Bromocriptine; Carbidopa; Dopa Decarboxylase; Dopamine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Norepinephrine; Parkinson Disease; Selegiline; Serotonin; Substance P; Tyrosine 3-Monooxygenase

1978
[Therapy of tparkinson's disease. Clinical and pharmacological viewpoints].
    Medizinische Klinik, 1979, Jul-13, Volume: 74, Issue:28-29

    Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Histamine H1 Antagonists; Humans; Levodopa; Monoamine Oxidase Inhibitors; MSH Release-Inhibiting Hormone; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Posture; Psychoses, Substance-Induced; Tremor

1979
Treatment of acute hepatic encephalopathy.
    The Netherlands journal of medicine, 1979, Volume: 22, Issue:6

    Topics: Acid-Base Imbalance; Acute Disease; Adrenal Cortex Hormones; Antacids; Anti-Bacterial Agents; Blood Coagulation Disorders; Bromocriptine; Cimetidine; Critical Care; Cross Circulation; Diuretics, Osmotic; Exchange Transfusion, Whole Blood; Extracorporeal Circulation; Gastrointestinal Hemorrhage; Hemoperfusion; Hepatic Encephalopathy; Hepatitis B Antibodies; Humans; Lactulose; Levodopa; Liver Circulation; Liver Transplantation; Neomycin; Parenteral Nutrition; Peritoneal Dialysis; Plasma; Renal Dialysis; Serum Albumin; Transplantation, Homologous

1979
Prolactin.
    The New England journal of medicine, 1978, Jan-26, Volume: 298, Issue:4

    Topics: Amenorrhea; Animals; Behavior, Animal; Breast Neoplasms; Bromocriptine; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Levodopa; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Rats; Stress, Physiological; Tranquilizing Agents

1978
Bromocriptine in Parkinsonism.
    British medical journal, 1978, May-27, Volume: 1, Issue:6124

    Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Psychoses, Substance-Induced

1978
Dopamine receptor stimulating agonists in the treatment of Parkinson's disease.
    Biomedicine / [publiee pour l'A.A.I.C.I.G.], 1979, Volume: 30, Issue:2

    Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Piribedil; Receptors, Dopamine

1979
Drug therapy: Bromocriptine.
    The New England journal of medicine, 1979, Oct-18, Volume: 301, Issue:16

    Topics: Acromegaly; Adenoma; Amantadine; Bromocriptine; Female; Galactorrhea; Growth Hormone; Humans; Infertility; Lactation; Levodopa; Male; Parkinson Disease; Pituitary Neoplasms; Pregnancy; Prolactin

1979
[Psychiatric manifestations induced by dopamine precursors or antagonists].
    Annales medico-psychologiques, 1979, Volume: 137, Issue:9

    Topics: Anxiety; Bromocriptine; Confusion; Dopamine Antagonists; Dreams; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride

1979
[Role of prolactin in carcinogenesis and growth of mammary and breast neoplasms in animals and in man].
    Voprosy onkologii, 1976, Volume: 22, Issue:12

    Topics: Animals; Benz(a)Anthracenes; Breast; Breast Neoplasms; Bromocriptine; Cell Differentiation; Cell Transformation, Neoplastic; Female; Humans; Levodopa; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Prolactin

1976
Drugs that affect the breast and lactation.
    Clinical obstetrics and gynecology, 1975, Volume: 18, Issue:2

    Topics: Androgens; Apomorphine; Barbiturates; Breast; Breast Neoplasms; Bromocriptine; Contraceptives, Oral, Hormonal; Estrogens; Female; Galactorrhea; Humans; Lactation; Levodopa; Male; Monoamine Oxidase Inhibitors; Nandrolone; Phenothiazines; Pregnancy; Progesterone; Prolactin; Psychotropic Drugs; Pyridoxine; Steroids

1975
Drug therapy of Parkinson's disease. An overview.
    European neurology, 1992, Volume: 32 Suppl 1

    Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease; Receptors, N-Methyl-D-Aspartate

1992
[Current therapeutic approach in Parkinson disease].
    Revue medicale de Bruxelles, 1992, Volume: 13, Issue:10

    Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Fetal Tissue Transplantation; Humans; Levodopa; Mesencephalon; Parkinson Disease; Selegiline; Vitamin E

1992
The treatment of chronic hepatic encephalopathy.
    Hepato-gastroenterology, 1991, Volume: 38, Issue:5

    Topics: Amantadine; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver Cirrhosis; Receptors, GABA-A

1991
Review and videotape recognition of idiopathic restless legs syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1991, Volume: 6, Issue:2

    Topics: Anti-Anxiety Agents; Arousal; Baclofen; Benzodiazepines; Bromocriptine; Carbamazepine; Clonidine; Humans; Levodopa; Narcotics; Restless Legs Syndrome; Sleep Stages; Videotape Recording

1991
Neuroactive drugs in growth disorders.
    Acta paediatrica Scandinavica. Supplement, 1990, Volume: 367

    Topics: Bromocriptine; Central Nervous System; Child; Clonidine; False Negative Reactions; Growth Disorders; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Pyridostigmine Bromide

1990
[Dopanergic agonists and schizophrenia].
    Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa, 1989, Volume: 14, Issue:4

    Topics: Bromocriptine; Dopamine Agents; Humans; Levodopa; Receptors, Dopamine; Schizophrenia

1989
Tardive dyskinesia: epidemiologic factors as a guide for prevention and management.
    Advances in biochemical psychopharmacology, 1985, Volume: 40

    Topics: Age Factors; Animals; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Haplorhini; Humans; Levodopa; Parasympatholytics; Reserpine; Risk

1985
Medical treatment of pituitary adenomas: effects on tumor growth.
    Journal of endocrinological investigation, 1985, Volume: 8, Issue:3

    Topics: Adenoma; Adrenocorticotropic Hormone; Bromocriptine; Dihydroergotoxine; Dopamine; Drug Administration Schedule; Ergolines; Growth Hormone; Levodopa; Lisuride; Metergoline; Methysergide; Pergolide; Pituitary Neoplasms; Prolactin; Tomography, X-Ray Computed

1985
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
    Psychosomatics, 1986, Volume: 27, Issue:3

    Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug Interactions; Ergolines; Humans; Levodopa; Libido; Memory; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Sexual Behavior; Substance-Related Disorders; Visual Perception

1986
[Differential diagnosis of hyperprolactinemia].
    Nihon rinsho. Japanese journal of clinical medicine, 1986, Volume: 44, Issue:3

    Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Humans; Hyperprolactinemia; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin; Prolactin Release-Inhibiting Factors; Thyrotropin-Releasing Hormone

1986
Chronic pharmacological manipulation of dopamine receptors in brain.
    Neuropharmacology, 1987, Volume: 26, Issue:7B

    Topics: Acetylcholine; Animals; Antipsychotic Agents; Brain; Bromocriptine; Corpus Striatum; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Pergolide; Receptors, Dopamine; Trifluoperazine

1987
[Parkinson disease. The clinical picture and therapy].
    Deutsche medizinische Wochenschrift (1946), 1988, Jun-16, Volume: 113, Issue:24

    Topics: Adrenergic beta-Antagonists; Amantadine; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease

1988
Receptor changes during chronic dopaminergic stimulation.
    Journal of neural transmission. Supplementum, 1988, Volume: 27

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Brain Diseases; Bromocriptine; Dopamine; Humans; Hydroxydopamines; Injections, Intraperitoneal; Levodopa; Neurotransmitter Agents; Oxidopamine; Parkinson Disease; Pergolide; Primates; Pyridines; Receptors, Dopamine; Substance Withdrawal Syndrome

1988
Clonidine treatment in children with short stature.
    Journal of endocrinological investigation, 1988, Volume: 11, Issue:10

    Topics: Body Height; Bromocriptine; Child; Clonidine; Growth Disorders; Growth Hormone; Humans; Levodopa

1988
New perspectives in the treatment of Parkinson's disease.
    Clinical neuropharmacology, 1986, Volume: 9 Suppl 1

    Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Selegiline; Sincalide

1986
'On-off' phenomenon: description, incidence and management.
    European neurology, 1987, Volume: 27 Suppl 1

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Humans; Levodopa; Monoamine Oxidase Inhibitors; Movement Disorders; Parkinson Disease; Selegiline

1987
Controversies in the management of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1986, Volume: 1, Issue:3

    Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Selegiline

1986
Long-term use of dopamine agonists in Parkinson's disease.
    Clinical neuropharmacology, 1985, Volume: 8, Issue:2

    Topics: Bromocriptine; Corpus Striatum; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Movement Disorders; Parkinson Disease; Pergolide; Receptors, Dopamine; Time Factors

1985
The controversial role of bromocriptine in Parkinson's disease.
    Clinical neuropharmacology, 1985, Volume: 8, Issue:2

    Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease; Time Factors

1985
Bromocriptine in Parkinson disease.
    Pharmacological reviews, 1985, Volume: 37, Issue:2

    Topics: Aged; Animals; Bromocriptine; Drug Administration Schedule; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease; Pergolide; Time Factors

1985
Update on the treatment of Parkinson's disease.
    Connecticut medicine, 1985, Volume: 49, Issue:10

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Synergism; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline; Time Factors

1985
Pharmacologic therapy of patients with pituitary tumors secreting prolactin, growth hormone and adrenocorticotropin.
    Advances in internal medicine, 1980, Volume: 25

    Topics: Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cyproheptadine; Ergolines; Estrogens; Female; Galactorrhea; Growth Hormone; Humans; Hypothalamus; Levodopa; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin

1980
Update on antiparkinsonian agents.
    Geriatrics, 1982, Volume: 37, Issue:9

    Topics: Aged; Amantadine; Antiparkinson Agents; Blood-Brain Barrier; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Selegiline; Vascular Resistance

1982
Perspectives in hepatic encephalopathy.
    The Journal of laboratory and clinical medicine, 1982, Volume: 100, Issue:4

    Topics: Amino Acids; Animals; Blood-Brain Barrier; Brain; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver; Neurotransmitter Agents; Toxins, Biological

1982
[Therapy of hepatic encephalopathy. Personal experience and a review of the literature].
    Giornale di clinica medica, 1982, Volume: 63, Issue:10

    Topics: Amino Acids; Ammonia; Bromocriptine; Electroencephalography; Fatty Acids; Hepatic Encephalopathy; Lactulose; Levodopa; Neomycin; Nervous System; Neurologic Examination; Neurotransmitter Agents; Sulfhydryl Compounds; Synaptic Transmission

1982
Dopamine receptors and hypertension. Physiologic and pharmacologic implications.
    The American journal of medicine, 1984, Oct-05, Volume: 77, Issue:4A

    Topics: Animals; Benzazepines; Blood Pressure; Bromocriptine; Domperidone; Dopamine; Ergolines; Fenoldopam; Humans; Hypertension; Levodopa; Quinpirole; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasoconstriction; Vasodilation

1984
[New directions in contemporary pharmacotherapy of parkinsonism (review)].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1984, Volume: 84, Issue:9

    Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antiparkinson Agents; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; gamma-Aminobutyric Acid; Humans; Levodopa; Lisuride; Oxprenolol; Parkinson Disease; Piracetam; Piribedil; Propranolol

1984
Progress in the treatment of chronic portasystemic encephalopathy.
    Gut, 1984, Volume: 25, Issue:1

    Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin

1984
The pharmacology of Parkinson's disease: basic aspects and recent advances.
    Experientia, 1984, Nov-15, Volume: 40, Issue:11

    Topics: Animals; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Bromocriptine; Carbidopa; Corpus Striatum; Dopamine; Ergolines; Humans; Kidney; Kinetics; Levodopa; Lisuride; Liver; Methyldopa; Norepinephrine; Parkinson Disease; Pergolide; Receptors, Dopamine; Selegiline; Serotonin; Stereotyped Behavior; Substantia Nigra; Tyramine

1984
Prolactin-producing pituitary tumors: medical therapy.
    Clinical obstetrics and gynecology, 1980, Volume: 23, Issue:2

    Topics: Bromocriptine; Female; Humans; Levodopa; Pituitary Neoplasms; Prolactin

1980
On the mechanism of the antiparkinsonian action of 1-DOPA and bromocriptine: a theoretical and experimental analysis of dopamine receptor sub- and supersensitivity.
    Journal of neural transmission. Supplementum, 1980, Issue:16

    Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Bromocriptine; Humans; Hydroxydopamines; Levodopa; Receptors, Dopamine

1980
[Antiestrogens in the treatment of breast cancer].
    Voprosy onkologii, 1981, Volume: 27, Issue:9

    Topics: Adult; Blood Proteins; Breast Neoplasms; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Estrogen Antagonists; Female; Homeostasis; Humans; Levodopa; Ligands; Male; Menopause; Middle Aged; Tamoxifen

1981
Is aldosterone secretion under dopaminergic control?
    Circulation research, 1981, Volume: 49, Issue:6

    Topics: Aldosterone; Bromocriptine; Chlorpromazine; Dopamine; Dopamine Antagonists; Edema; Humans; Levodopa; Methyldopa; Metoclopramide; Parkinson Disease; Sulpiride

1981
The management of Parkinson's disease.
    Australian and New Zealand journal of medicine, 1982, Volume: 12, Issue:2

    Topics: Adult; Aged; Amantadine; Bromocriptine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Humans; Hypotension, Orthostatic; Levodopa; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease

1982
[Stage-adjusted treatment of idiopathic Parkinson syndrome].
    Wiener medizinische Wochenschrift (1946), 1995, Volume: 145, Issue:13

    Topics: Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Cholinergic Antagonists; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Selegiline

1995
Levodopa and dopamine agonists in the treatment of Parkinson's disease: advantages and disadvantages.
    European neurology, 1994, Volume: 34 Suppl 3

    Topics: Animals; Brain; Bromocriptine; Corpus Striatum; Dopamine Agonists; Free Radicals; Humans; Levodopa; Mice; Parkinson Disease; Parkinson Disease, Secondary; Premedication; Reactive Oxygen Species; Receptors, Dopamine D1; Receptors, Dopamine D2; Synaptic Transmission

1994
[Recent progress of therapy in patients with Parkinson's disease].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1993, Jul-10, Volume: 82, Issue:7

    Topics: Brain; Bromocriptine; Delayed-Action Preparations; Droxidopa; Drug Resistance; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Dopamine

1993
Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1993, Volume: 8, Issue:3

    Topics: Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome

1993
Treatment of early Parkinson's disease: are complicated strategies justified?
    Mayo Clinic proceedings, 1996, Volume: 71, Issue:7

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Selegiline

1996
Drug management of Parkinson's disease.
    Canadian family physician Medecin de famille canadien, 1996, Volume: 42

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Selegiline; Trihexyphenidyl

1996
New directions in the drug treatment of Parkinson's disease.
    Drugs & aging, 1996, Volume: 9, Issue:3

    Topics: Antiparkinson Agents; Apomorphine; Bromocriptine; Dopamine Agonists; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Selegiline

1996
[Treatment of Parkinson's disease with multiple drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1

    Topics: Amantadine; Bromocriptine; Cholinergic Antagonists; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide

1997
Clinical experience with cabergoline in patients with advanced Parkinson's disease treated with levodopa.
    Drugs, 1998, Volume: 55 Suppl 1

    Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Randomized Controlled Trials as Topic

1998
[Toxic and adverse neurological effects of anti-parkinsonian drugs].
    Ryoikibetsu shokogun shirizu, 1999, Issue:27 Pt 2

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Cholinergic Antagonists; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroleptic Malignant Syndrome; Psychoses, Substance-Induced; Substance-Related Disorders

1999
The initial treatment of Parkinson's disease should begin with levodopa.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors

1999
Treatment of Parkinson's disease should begin with a dopamine agonist.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5

    Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles

1999
The efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Levodopa; Neurologic Examination; Parkinson Disease; Randomized Controlled Trials as Topic; Treatment Outcome

2000
Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Pergolide

2000
Bromocriptine for levodopa-induced motor complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Dystonia; Humans; Levodopa; Parkinson Disease

2000
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Humans; Levodopa; Lisuride; Parkinson Disease

2000
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2000, Issue:3

    Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

2000
Bromocriptine versus levodopa in early Parkinson's disease.
    The Cochrane database of systematic reviews, 2000, Issue:3

    Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

2000
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2000, Issue:3

    Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles

2000
[The new Parkinson's disease drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 2000, Volume: 58, Issue:10

    Topics: Antiparkinson Agents; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease

2000
[Parkinson disease: diagnostic and therapeutic criteria].
    Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8

    Topics: Activities of Daily Living; Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Globus Pallidus; Humans; Indoles; Levodopa; Lewy Body Disease; Lisuride; Male; Mental Status Schedule; Neurosurgery; Parkinson Disease; Parkinsonian Disorders; Piribedil; Psychiatric Status Rating Scales; Serotonin Receptor Agonists; Stereotaxic Techniques; Supranuclear Palsy, Progressive; Surveys and Questionnaires; Thalamus

2001
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2001, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Indoles; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

2001
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2001, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

2001
Clinical management of neuroleptic malignant syndrome.
    The Psychiatric quarterly, 2001,Winter, Volume: 72, Issue:4

    Topics: Bromocriptine; Carbidopa; Dopamine Agonists; Drug Combinations; Electroconvulsive Therapy; Guidelines as Topic; Humans; Levodopa; Neuroleptic Malignant Syndrome; Physical Therapy Specialty

2001
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
    The Cochrane database of systematic reviews, 2002, Issue:2

    Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

2002
DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17 Suppl 4

    Topics: Benzophenones; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Therapy, Combination; Enzyme Inhibitors; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Nitrophenols; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Tolcapone

2002
Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
    Journal of neurology, 2002, Volume: 249 Suppl 2

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Contraindications; Disease Models, Animal; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine

2002
[Neuroleptic malignant syndrome].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:1

    Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis

2002
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Revue neurologique, 2003, Volume: 159, Issue:4

    Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease

2003
Catechol-O-methyltransferase inhibitors versus active comparators for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4

    Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dopamine Agonists; Humans; Levodopa; Nitrophenols; Parkinson Disease; Pergolide; Tolcapone

2004
Ropinirole: current status of the studies.
    Journal of neurology, 2004, Volume: 251 Suppl 6

    Topics: Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Indoles; Levodopa; Neuroprotective Agents; Parkinson Disease

2004
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone

2005
Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury.
    Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:6

    Topics: Amantadine; Animals; Brain Injuries; Bromocriptine; Cognition Disorders; Dextroamphetamine; Humans; Levodopa; Methylphenidate

2005
Bromocriptine versus levodopa in early Parkinson's disease.
    The Cochrane database of systematic reviews, 2007, Oct-17, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

2007
Bromocriptine/levodopa combined versus levodopa alone for early Parkinson's disease.
    The Cochrane database of systematic reviews, 2007, Oct-17, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

2007
Treatment of portal systemic encephalopathy: standard and new treatments.
    Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 1990, Volume: 42 Suppl

    Topics: Bromocriptine; Clinical Trials as Topic; Colon; Dietary Proteins; Disaccharides; Double-Blind Method; Enema; GABA Antagonists; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Laxatives; Levodopa; Liver Cirrhosis; Malnutrition; Metabolic Networks and Pathways; Plant Proteins, Dietary; Sodium Benzoate; Zinc

1990
Acute management of acquired brain injury Part III: an evidence-based review of interventions used to promote arousal from coma.
    Brain injury, 2010, Volume: 24, Issue:5

    Topics: Amantadine; Arousal; Brain Injuries; Bromocriptine; Coma, Post-Head Injury; Dopamine Agonists; Evidence-Based Medicine; Humans; Levodopa; Music Therapy; Randomized Controlled Trials as Topic; Recovery of Function

2010
Dopamine agonists for the treatment of cocaine dependence.
    The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

    Topics: Amantadine; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic

2011
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
    Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7

    Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline

2013
Dopamine agents for hepatic encephalopathy.
    The Cochrane database of systematic reviews, 2014, Feb-10, Issue:2

    Topics: Bromocriptine; Dopamine Agonists; Hepatic Encephalopathy; Humans; Levodopa; Randomized Controlled Trials as Topic

2014
Pharmacotherapy for sleep bruxism.
    The Cochrane database of systematic reviews, 2014, Oct-23, Issue:10

    Topics: Amitriptyline; Bromocriptine; Clonidine; Humans; Levodopa; Propranolol; Randomized Controlled Trials as Topic; Sleep Bruxism; Tryptophan

2014
Dopamine agonists for the treatment of cocaine dependence.
    The Cochrane database of systematic reviews, 2015, May-27, Issue:5

    Topics: Amantadine; Antidepressive Agents; Bromocriptine; Cocaine-Related Disorders; Depression; Dopamine Agonists; Humans; Levodopa; Randomized Controlled Trials as Topic; Selection Bias

2015
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis.
    Scientific reports, 2017, 04-04, Volume: 8

    Topics: Bromocriptine; Cluster Analysis; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Network Meta-Analysis; Parkinson Disease; Picolinic Acids; Pramipexole; Selegiline; Tetrahydronaphthalenes; Thiophenes

2017
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis.
    European journal of pharmacology, 2023, Sep-05, Volume: 954

    Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole

2023

Trials

118 trial(s) available for bromocriptine and levodopa

ArticleYear
[Dopamine-receptor stimulators and neuroleptic-induced dyskinesia (author's transl)].
    Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1978, Volume: 11, Issue:6

    Topics: Antipsychotic Agents; Bromocriptine; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Levodopa; Receptors, Dopamine; Schizophrenia; Time Factors; Trihexyphenidyl

1978
Letter: Bromocriptine in parkinsonism.
    Lancet (London, England), 1975, Nov-15, Volume: 2, Issue:7942

    Topics: Bromocriptine; Drug Evaluation; Ergolines; Humans; Levodopa; Parkinson Disease

1975
Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
    Lancet (London, England), 1976, Aug-07, Volume: 2, Issue:7980

    Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation; Ergolines; Female; Follow-Up Studies; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors

1976
Bromocriptine in Parkinson's disease.
    Lancet (London, England), 1978, Sep-09, Volume: 2, Issue:8089

    Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Piperidines; Thioxanthenes; Trihexyphenidyl

1978
Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release.
    Life sciences, 1978, Volume: 22, Issue:10

    Topics: Adult; Bromocriptine; Carbidopa; Chlorpromazine; Dopamine; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Placebos; Prolactin; Time Factors

1978
An ergot derivative in the treatment of Parkinson's disease.
    Postgraduate medical journal, 1976, Volume: 52suppl 1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Parkinson Disease

1976
Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome.
    Acta endocrinologica. Supplementum, 1978, Volume: 216

    Topics: Animals; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease, Secondary; Rats; Receptors, Adrenergic, alpha; Receptors, Dopamine

1978
Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
    Acta endocrinologica, 1977, Volume: 84, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Benserazide; Bromocriptine; Clinical Trials as Topic; Drug Interactions; Ergolines; Female; Humans; Hydrazines; Levodopa; Male; Metergoline; Methysergide; Middle Aged; Pituitary Gland; Pituitary Gland, Anterior; Prolactin; Secretory Rate; Stimulation, Chemical; Time Factors

1977
[Treatment of parkinsonian syndromes by bromocriptin].
    La Nouvelle presse medicale, 1977, Jan-22, Volume: 6, Issue:3

    Topics: Aged; Amantadine; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Hypotension; Levodopa; Male; Movement Disorders; Nausea; Parkinson Disease, Secondary

1977
Comparison of the effects of bromocriptine and levodopa in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:5

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Humans; Individuality; Levodopa; Male; Middle Aged; Parkinson Disease

1977
Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
    Acta neurologica Scandinavica, 1977, Volume: 56, Issue:3

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos

1977
Bromocriptine in the treatment of advanced Parkinsonism.
    Acta neurologica Scandinavica, 1977, Volume: 56, Issue:3

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos

1977
Treatment of Parkinson's disease with lergotrile mesylate.
    JAMA, 1977, Nov-28, Volume: 238, Issue:22

    Topics: Acetonitriles; Antiparkinson Agents; Bromocriptine; Carbidopa; Carboxy-Lyases; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease

1977
Bromocryptine in levodopa response-losing parkinsonism. A double blind study.
    European neurology, 1978, Volume: 17, Issue:2

    Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Placebos; Psychiatric Status Rating Scales

1978
Restatement and prospectives of ergot alkaloids in clinical neurology and psychiatry.
    Pharmacology, 1978, Volume: 16 Suppl 1

    Topics: Aged; Amantadine; Basal Ganglia Diseases; Bromocriptine; Chorea; Clinical Trials as Topic; Depression; Drug Evaluation; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents

1978
Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa.
    Journal of neurology, neurosurgery, and psychiatry, 1978, Volume: 41, Issue:12

    Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Syndrome

1978
A double-blind trial of bromocriptine in Parkinson's disease.
    The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:3 Suppl

    Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease

1978
An evaluation of bromocriptine in the treatment of Parkinson's disease.
    Clinical and experimental neurology, 1978, Volume: 15

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease

1978
Inhibition of cimetidine-induced hyperprolactinaemia by pretreatment with levodopa or bromocriptine.
    Clinical endocrinology, 1979, Volume: 10, Issue:1

    Topics: Adult; Bromocriptine; Cimetidine; Guanidines; Humans; Levodopa; Male; Middle Aged; Prolactin

1979
Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial.
    Acta neurologica Scandinavica, 1976, Volume: 53, Issue:3

    Topics: Aged; Azides; Benserazide; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Combinations; Ergolines; Female; Humans; Hydrazines; Hyperkinesis; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychoses, Substance-Induced

1976
Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism.
    Neurology, 1976, Volume: 26, Issue:6 PT 1

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Tremor

1976
[Clinical experience with bromocriptine, a central dopaminergic stimulator].
    Der Nervenarzt, 1976, Volume: 47, Issue:11

    Topics: Aged; Amantadine; Bromocriptine; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Trihexyphenidyl

1976
Combined anti-prolactin and anti-oestrogen therapy for breast carcinoma.
    Clinical oncology, 1977, Volume: 3, Issue:1

    Topics: Aged; Breast Neoplasms; Bromocriptine; Carbidopa; Drug Therapy, Combination; Estrogen Antagonists; Female; Humans; Levodopa; Middle Aged; Nausea; Prolactin; Remission, Spontaneous; Stilbenes; Tamoxifen; Time Factors; Vomiting

1977
Dopaminergic agonists in Parkinsonism.
    Advances in neurology, 1975, Volume: 9

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos

1975
The evolution of dementia in idiopathic Parkinson's disease: neuropsychological and clinical evidence in support of subtypes.
    International psychogeriatrics, 1992, Volume: 4 Suppl 2

    Topics: Age Factors; Aged; Bromocriptine; Carbidopa; Dementia; Drug Therapy, Combination; Female; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease

1992
Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients: analysis on the maintenance and the change of the original mode of treatment.
    European neurology, 1992, Volume: 32 Suppl 1

    Topics: Activities of Daily Living; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Gait; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease

1992
Primary combination therapy of early Parkinson's disease. A long-term comparison between the combined regimen bromocriptine/levodopa and levodopa monotherapy--first interim report.
    European neurology, 1992, Volume: 32 Suppl 1

    Topics: Benserazide; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease; Prospective Studies; Psychomotor Performance

1992
Nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients. Final report.
    European neurology, 1992, Volume: 32 Suppl 1

    Topics: Activities of Daily Living; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies

1992
Bromocriptine lessens the incidence of mortality in L-dopa-treated parkinsonian patients: prado-study discontinued.
    European journal of clinical pharmacology, 1992, Volume: 43, Issue:4

    Topics: Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Performance

1992
Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease.
    Acta neurologica Scandinavica, 1992, Volume: 86, Issue:6

    Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease

1992
Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients.
    Brain : a journal of neurology, 1992, Volume: 115 ( Pt 6)

    Topics: Adult; Aged; Bromocriptine; Cognition Disorders; Female; Follow-Up Studies; Frontal Lobe; Humans; Levodopa; Male; Memory Disorders; Middle Aged; Motor Activity; Movement; Parasympatholytics; Parkinson Disease; Psychomotor Performance; Visual Perception

1992
Parlodel SRO in Parkinson's disease: a double-blind randomized comparison of Parlodel standard and Parlodel SRO.
    European neurology, 1992, Volume: 32, Issue:6

    Topics: Administration, Oral; Aged; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease

1992
[A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 1992, Volume: 94, Issue:3

    Topics: Amantadine; Antiparkinson Agents; Biperiden; Bromocriptine; Electroencephalography; Glycolates; Humans; Levodopa; Male; Psychotropic Drugs; Thiophenes; Trihexyphenidyl

1992
Comparison of three regimens of Parlodel-SRO in levodopa-treated parkinsonians: a randomized double-blind crossover study.
    International journal of clinical pharmacology, therapy, and toxicology, 1991, Volume: 29, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Behavior; Bromocriptine; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1991
A nationwide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. The fourth interim report.
    European neurology, 1991, Volume: 31 Suppl 1

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Motor Skills; Neurologic Examination; Parkinson Disease

1991
Simplification of the initiation of bromocriptine in elderly patients with advanced Parkinson's disease.
    Age and ageing, 1991, Volume: 20, Issue:2

    Topics: Aged; Aged, 80 and over; Bromocriptine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1991
Third interim report of the nationwide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
    European neurology, 1990, Volume: 30 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Japan; Levodopa; Middle Aged; Multicenter Studies as Topic; Parkinson Disease

1990
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Revue neurologique, 1990, Volume: 146, Issue:2

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease; Prospective Studies; Psychomotor Disorders; Randomized Controlled Trials as Topic

1990
Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
    Advances in neurology, 1990, Volume: 53

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Europe; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease

1990
Adjunctive therapy with bromocriptine in Parkinson's disease.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1990, Dec-01, Volume: 78, Issue:11

    Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1990
Long-term double masked trial of early treatment with L-dopa plus bromocriptine versus L-dopa alone in Parkinson's disease. Interim results.
    European neurology, 1990, Volume: 30, Issue:2

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Humans; Levodopa; Middle Aged; Parkinson Disease, Secondary

1990
The effect of dietary protein on the efficacy of L-dopa: a double-blind study.
    Neurology, 1989, Volume: 39, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dietary Proteins; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation; Selegiline

1989
Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer.
    Breast cancer research and treatment, 1989, Volume: 14, Issue:3

    Topics: Aged; Blood Glucose; Breast Neoplasms; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Female; Growth Hormone; Hormones; Humans; Insulin-Like Growth Factor I; Levodopa; Middle Aged; Pilot Projects; Prolactin; Prospective Studies; Somatostatin

1989
The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.
    Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:3

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation

1989
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
    Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:6

    Topics: Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Random Allocation

1989
The addition of bromocriptine to long-term dopa therapy in Parkinson's disease.
    Clinical and experimental neurology, 1989, Volume: 26

    Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Drug Therapy, Combination; Gait; Humans; Levodopa; Middle Aged; Parkinson Disease

1989
Long term bromocriptine treatment in de novo parkinsonian patients.
    Medicina, 1988, Volume: 48, Issue:4

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation

1988
A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
    European neurology, 1988, Volume: 28 Suppl 1

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Parkinson Disease; Random Allocation

1988
A progress report on the New Zealand Multicentre Parkinson's disease trial. A comparison of low-dose treatment with bromocriptine or L-dopa.
    European neurology, 1988, Volume: 28 Suppl 1

    Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; Parkinson Disease; Prospective Studies

1988
A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:4

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Follow-Up Studies; Humans; Levodopa; Neurologic Examination; Parkinson Disease

1987
A nation-wide collaborative study on the long-term effects of bromocriptine in patients with Parkinson's disease. First interim report in Japan.
    European neurology, 1988, Volume: 28 Suppl 1

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Prospective Studies

1988
Patients sought for New Zealand multi-centre Parkinson's disease trial.
    The New Zealand medical journal, 1987, Jan-28, Volume: 100, Issue:816

    Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; New Zealand; Parkinson Disease

1987
Restless legs syndrome treatment with dopaminergic drugs.
    Clinical neuropharmacology, 1987, Volume: 10, Issue:1

    Topics: Adult; Aged; Benserazide; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Piribedil; Random Allocation; Restless Legs Syndrome; Sleep Initiation and Maintenance Disorders

1987
Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
    Advances in neurology, 1987, Volume: 45

    Topics: Aged; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Random Allocation

1987
Treatment of early morning akinesia with low-dose bromocriptine.
    Advances in neurology, 1987, Volume: 45

    Topics: Aged; Aged, 80 and over; Bromocriptine; Clinical Trials as Topic; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease

1987
The Sydney multicentre study of Parkinson's disease. The first 18 months.
    The Medical journal of Australia, 1987, Feb-16, Volume: 146, Issue:4

    Topics: Australia; Bromocriptine; Carbidopa; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans; Levodopa; Parkinson Disease

1987
Bromocriptine and the clinical spectrum of Parkinson's disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl

    Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1987
Low dosages of bromocriptine added to levodopa in Parkinson's disease.
    Neurology, 1985, Volume: 35, Issue:2

    Topics: Adult; Aged; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease

1985
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism.
    Journal of neural transmission, 1985, Volume: 64, Issue:1

    Topics: Adult; Aged; Blood Pressure; Bromocriptine; Drug Administration Schedule; Ergolines; Female; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1985
Adjuvant treatment of Parkinson's disease with dopamine agonists: open trial with bromocriptine and CU 32-085.
    Journal of neurology, 1982, Volume: 227, Issue:2

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine

1982
Comparison of pergolide and bromocriptine therapy in parkinsonism.
    Neurology, 1983, Volume: 33, Issue:8

    Topics: Aged; Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide

1983
Progress in the treatment of chronic portasystemic encephalopathy.
    Gut, 1984, Volume: 25, Issue:1

    Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin

1984
[Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Deutsche medizinische Wochenschrift (1946), 1984, Aug-24, Volume: 109, Issue:34

    Topics: Aged; Benserazide; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Random Allocation; Time Factors

1984
Effect of apomorphine, a dopamine receptor agonist, on penile tumescence in normal subjects.
    Progress in neuro-psychopharmacology & biological psychiatry, 1984, Volume: 8, Issue:4-6

    Topics: Adult; Apomorphine; Benztropine; Bromocriptine; Cholinergic Fibers; Dopamine; Drug Interactions; Humans; Levodopa; Male; Middle Aged; Penis

1984
Pergolide in late-stage Parkinson disease.
    Annals of neurology, 1982, Volume: 12, Issue:3

    Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Sleep Wake Disorders

1982
Prolactin secretion in Parkinson disease.
    Neurology, 1981, Volume: 31, Issue:10

    Topics: Adult; Aged; Blood-Brain Barrier; Bromocriptine; Carbidopa; Dopamine; Drug Combinations; Female; Humans; Hypothalamus, Anterior; Levodopa; Male; Middle Aged; Parkinson Disease; Pituitary Gland; Placebos; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone

1981
Assessment of hypokinesia in Parkinsonism.
    Journal of neural transmission, 1981, Volume: 51, Issue:1-2

    Topics: Adult; Aged; Bromocriptine; Clinical Trials as Topic; Ergolines; Humans; Levodopa; Lisuride; Male; Middle Aged; Motor Activity; Movement; Parkinson Disease; Placebos; Posture; Time Factors

1981
Recent advances in the treatment of Parkinson's disease: the role of bromocriptine.
    Journal of neural transmission, 1981, Volume: 51, Issue:1-2

    Topics: Bromocriptine; Carbidopa; Clinical Trials as Topic; Follow-Up Studies; Humans; Levodopa; Parkinson Disease

1981
The effect of bromocriptine (BCT) on the on-off phenomenon.
    Journal of neural transmission, 1981, Volume: 52, Issue:1-2

    Topics: Bromocriptine; Clinical Trials as Topic; Humans; Levodopa; Parkinson Disease

1981
Weekly drug holiday in Parkinson disease.
    Neurology, 1981, Volume: 31, Issue:11

    Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1981
Bromocriptine and domperidone in the treatment of Parkinson disease.
    Neurology, 1981, Volume: 31, Issue:6

    Topics: Benzimidazoles; Bromocriptine; Domperidone; Female; Humans; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Piperidines; Vomiting

1981
Bromocriptine: low-dose therapy in Parkinson disease.
    Neurology, 1982, Volume: 32, Issue:6

    Topics: Aged; Bromocriptine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Placebos; Tremor

1982
The effect of deprenyl and levodopa on the progression of Parkinson's disease.
    Annals of neurology, 1995, Volume: 38, Issue:5

    Topics: Aged; Analysis of Variance; Antiparkinson Agents; Bromocriptine; Carbidopa; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Humans; Least-Squares Analysis; Levodopa; Male; Parkinson Disease; Prospective Studies; Selegiline; Statistics, Nonparametric; Treatment Outcome

1995
A crossover, controlled study comparing pergolide with bromocriptine as an adjunct to levodopa for the treatment of Parkinson's disease.
    Neurology, 1995, Volume: 45, Issue:3 Suppl 3

    Topics: Aged; Bromocriptine; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide

1995
Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4

    Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Pergolide; Single-Blind Method; Treatment Outcome

1994
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:4

    Topics: Aged; Bromocriptine; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Naltrexone; Neurologic Examination; Parkinson Disease

1994
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:8

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Prevalence; Prospective Studies; Severity of Illness Index; Survival Analysis; Treatment Failure

1994
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
    Journal of neurology, neurosurgery, and psychiatry, 1994, Volume: 57, Issue:9

    Topics: Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pilot Projects; Prospective Studies

1994
Visual control of arm movement in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:1

    Topics: Adult; Aged; Attention; Benserazide; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Orientation; Parkinson Disease; Psychomotor Performance; Reaction Time; Selegiline

1994
Progress note on Japanese multicenter bromocriptine monotherapy.
    European neurology, 1993, Volume: 33 Suppl 1

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Japan; Levodopa; Long-Term Care; Neurologic Examination; Parkinson Disease

1993
Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
    BMJ (Clinical research ed.), 1993, Aug-21, Volume: 307, Issue:6902

    Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Selegiline; Treatment Outcome

1993
Early combination therapy (bromocriptine and levodopa) does not prevent motor fluctuations in Parkinson's disease.
    Neurology, 1993, Volume: 43, Issue:1

    Topics: Activities of Daily Living; Aged; Bromocriptine; Chorea; Double-Blind Method; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease

1993
[L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
    Lakartidningen, 1993, Apr-21, Volume: 90, Issue:16

    Topics: Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Hyperkinesis; Levodopa; Male; Motor Activity; Parkinson Disease; Time Factors

1993
Effect of age and disease duration on parkinsonian motor scores under levodopa therapy.
    Journal of neural transmission. Parkinson's disease and dementia section, 1995, Volume: 9, Issue:2-3

    Topics: Adult; Aged; Aging; Antiparkinson Agents; Bromocriptine; Disease Progression; Female; Gait; Humans; Levodopa; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Psychomotor Performance; Tremor

1995
A "combined" levodopa test as a useful method for evaluating the efficacy of dopamine agonists: application to pergolide and bromocriptine.
    Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:5

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide

1995
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
    BMJ (Clinical research ed.), 1995, Dec-16, Volume: 311, Issue:7020

    Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Cause of Death; Disability Evaluation; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Proportional Hazards Models; Prospective Studies; Selegiline; Time Factors; Treatment Failure

1995
Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS).
    Journal of neural transmission. General section, 1995, Volume: 99, Issue:1-3

    Topics: Aged; Benzamides; Brain; Brain Chemistry; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Levodopa; Male; Middle Aged; Myoclonus; Polysomnography; Pyrrolidines; Receptors, Dopamine D2; Sleep Wake Disorders; Tomography, Emission-Computed, Single-Photon

1995
Bromocriptine therapy in early-stage Parkinson's disease.
    European neurology, 1996, Volume: 36, Issue:3

    Topics: Antiparkinson Agents; Bromocriptine; Disease Progression; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Time Factors; Treatment Outcome

1996
Age at onset: the major determinant of outcome in Parkinson's disease.
    Acta neurologica Scandinavica, 1995, Volume: 92, Issue:6

    Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Postural Balance; Treatment Outcome; Tremor

1995
Eight-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
    European neurology, 1996, Volume: 36 Suppl 1

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Japan; Levodopa; Male; Middle Aged; Parkinson Disease

1996
Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.
    Journal of neural transmission (Vienna, Austria : 1996), 1996, Volume: 103, Issue:6

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Incidence; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Parkinson Disease; Prospective Studies; Time Factors

1996
Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
    Clinical neuropharmacology, 1997, Volume: 20, Issue:1

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Placebos; Prospective Studies

1997
Nine-year follow-up study of bromocriptine monotherapy for Parkinson's disease.
    European neurology, 1997, Volume: 38 Suppl 1

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1997
Tolcapone, bromocriptine, and Parkinson's disease. French Tolcapone Study Group.
    Lancet (London, England), 1997, Sep-06, Volume: 350, Issue:9079

    Topics: Antiparkinson Agents; Benzophenones; Bromocriptine; Drug Therapy, Combination; Drug Tolerance; Humans; Levodopa; Nitrophenols; Parkinson Disease; Tolcapone

1997
Discontinuation of prolonged bromocriptine therapy in Parkinson's disease patients with uncontrolled motor oscillations.
    Clinical neuropharmacology, 1994, Volume: 17, Issue:5

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies

1994
Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-up.
    European neurology, 1997, Volume: 38 Suppl 2

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Japan; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Parkinson Disease

1997
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:6

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Severity of Illness Index

1997
Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs.
    Electroencephalography and clinical neurophysiology, 1997, Volume: 105, Issue:6

    Topics: Administration, Oral; Adult; Analysis of Variance; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Electromyography; Evoked Potentials, Motor; Female; Haloperidol; Humans; Levodopa; Magnetics; Male; Motor Cortex; Physical Stimulation; Reference Values; Selegiline; Sulpiride

1997
Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry
    BMJ (Clinical research ed.), 1998, Apr-18, Volume: 316, Issue:7139

    Topics: Antiparkinson Agents; Bromocriptine; Cause of Death; Disabled Persons; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Parkinson Disease; Proportional Hazards Models; Selegiline; Survival Rate; Treatment Failure

1998
Is stereotactic surgical treatment still necessary for Parkinson's disease in the contemporary trend of medical therapy with dopamine receptor agonist?
    Stereotactic and functional neurosurgery, 1997, Volume: 69, Issue:1-4 Pt 2

    Topics: Aged; Aged, 80 and over; Bromocriptine; Carbidopa; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Female; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Stereotaxic Techniques; Treatment Outcome

1997
Efficacy and tolerability of tolcapone compared with bromocriptine in levodopa-treated parkinsonian patients. Tolcapone Study Group.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Aged; Antiparkinson Agents; Benzophenones; Bromocriptine; Catechol O-Methyltransferase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Nitrophenols; Parkinson Disease; Tolcapone; Treatment Outcome

1999
A 3-year randomized trial of ropinirole and bromocriptine in early Parkinson's disease. The 053 Study Group.
    Neurology, 1999, Jul-22, Volume: 53, Issue:2

    Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1999
Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Movement disorders : official journal of the Movement Disorder Society, 2000, Volume: 15, Issue:3

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Disability Evaluation; Disease Progression; Double-Blind Method; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Prospective Studies; Selegiline; Substance Withdrawal Syndrome

2000
Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease.
    Journal of neurology, 2000, Volume: 247, Issue:11

    Topics: Aged; Blood Pressure; Bromocriptine; Cardiovascular System; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline

2000
Suppressed sympathetic skin response in Parkinson disease.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2000, Volume: 10, Issue:6

    Topics: Acoustic Stimulation; Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Electric Stimulation; Evoked Potentials; Evoked Potentials, Auditory; Female; Foot; Hand; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Reaction Time; Reference Values; Selegiline; Skin; Sympathetic Nervous System

2000
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:3

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; France; Humans; Levodopa; Male; Middle Aged; Mortality; Parkinson Disease; Prospective Studies; Treatment Outcome

2001
Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial.
    Neurology, 2001, Nov-13, Volume: 57, Issue:9

    Topics: Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Disability Evaluation; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Incidence; Levodopa; Male; Parkinson Disease; Selegiline; Treatment Outcome

2001
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
    Journal of neural transmission (Vienna, Austria : 1996), 2002, Volume: 109, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Hallucinations; Humans; Indoles; Levodopa; Logistic Models; Male; Middle Aged; Odds Ratio; Parkinson Disease

2002
Ropinirole for the treatment of tremor in early Parkinson's disease.
    European journal of neurology, 2002, Volume: 9, Issue:3

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Double-Blind Method; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Treatment Outcome; Tremor

2002
Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
    Archives of neurology, 2002, Volume: 59, Issue:5

    Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Treatment Outcome

2002
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:5

    Topics: Activities of Daily Living; Aged; Bromocriptine; Carbidopa; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Withholding Treatment

2002
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Journal of neurology, 2003, Volume: 250, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Treatment Outcome

2003
Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating.
    Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:3

    Topics: Acoustic Stimulation; Adult; Brain; Bromocriptine; Cross-Over Studies; Dopamine Agents; Dopamine Agonists; Double-Blind Method; Electroencephalography; Evoked Potentials, Auditory; Homovanillic Acid; Humans; Levodopa; Male; Prolactin; Sensory Deprivation; Time Factors

2004
No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:6

    Topics: Adult; Antiparkinson Agents; Attention; Bromocriptine; Cross-Over Studies; Dopamine; Dopamine Agonists; Double-Blind Method; Electroencephalography; Electrooculography; Event-Related Potentials, P300; Homovanillic Acid; Humans; Levodopa; Male; Prolactin; Psychomotor Performance; Psychophysiology; Receptors, Dopamine D2

2006
Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD.
    Neurology, 2008, Aug-12, Volume: 71, Issue:7

    Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Quality of Life; Selegiline

2008
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
    British journal of clinical pharmacology, 2009, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult

2009
Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Dec-15, Volume: 24, Issue:16

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Parkinson Disease; Prospective Studies; Rheology; Severity of Illness Index; Statistics, Nonparametric; Urinary Bladder Diseases; Urodynamics

2009
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:3

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3

2013

Other Studies

415 other study(ies) available for bromocriptine and levodopa

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Central dopaminergic and serotoninergic systems in the regulation of adrenal tyrosine hydroxylase.
    Journal of neurochemistry, 1977, Volume: 28, Issue:1

    Topics: 5-Hydroxytryptophan; 5,6-Dihydroxytryptamine; Adrenal Glands; Animals; Apomorphine; Bromocriptine; Carbidopa; Clonidine; Dopamine; Drug Interactions; Haloperidol; Hydroxydopamines; Injections, Intraventricular; Kinetics; Levodopa; Male; Piribedil; Pituitary Gland; Rats; Serotonin; Serotonin Antagonists; Splanchnic Nerves; Tyrosine 3-Monooxygenase

1977
Update on drug treatment of Parkinsonism.
    American family physician, 1977, Volume: 16, Issue:1

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1977
The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Federation proceedings, 1978, Volume: 37, Issue:8

    Topics: Acetonitriles; Amenorrhea; Bromocriptine; Dopamine; Ergolines; Ergot Alkaloids; Female; Galactorrhea; Humans; Levodopa; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactin Release-Inhibiting Factors

1978
Dopaminephilic properties of ergot alkaloids.
    Federation proceedings, 1978, Volume: 37, Issue:8

    Topics: Acetonitriles; Animals; Bromocriptine; Corpus Striatum; Ergolines; Ergot Alkaloids; Haplorhini; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine; Spiperone; Substantia Nigra; Synaptosomes; Tremor; Tyrosine 3-Monooxygenase

1978
Lergotrile in Parkinson disease: further studies.
    Neurology, 1979, Volume: 29, Issue:2

    Topics: Aged; Bromocriptine; Chemical Phenomena; Chemistry; Dopa Decarboxylase; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease

1979
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
    Arzneimittel-Forschung, 1978, Volume: 28, Issue:10

    Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Electromyography; Gluconates; Levodopa; Lisuride; Male; Motor Neurons; Muscle Contraction; Niacinamide; Parkinson Disease, Secondary; Rats; Reserpine; RNA; Spinal Cord; Sugar Phosphates

1978
Letter: Prolactin, levodopa, and migraine.
    Lancet (London, England), 1975, Apr-05, Volume: 1, Issue:7910

    Topics: Bromocriptine; Ergolines; Humans; Levodopa; Migraine Disorders; Prolactin

1975
Letter: Growth-hormone responses in Parkinson's disease.
    Lancet (London, England), 1976, Feb-28, Volume: 1, Issue:7957

    Topics: Bromocriptine; Growth Hormone; Humans; Levodopa; Parkinson Disease

1976
Letter: Psychosis in patient on bromocriptine and levodopa with carbidopa.
    Lancet (London, England), 1976, Sep-11, Volume: 2, Issue:7985

    Topics: Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Middle Aged; Parkinson Disease; Schizophrenia, Paranoid

1976
Long-term treatment of parkinsonism with bromocriptine.
    Lancet (London, England), 1978, Apr-08, Volume: 1, Issue:8067

    Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Time Factors

1978
Drugs for Parkinson's disease.
    Lancet (London, England), 1978, Apr-08, Volume: 1, Issue:8067

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Drug Evaluation; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Phenethylamines

1978
Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study.
    Journal of neurology, 1978, Apr-14, Volume: 218, Issue:1

    Topics: Aged; Bromocriptine; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Myoclonus; Parkinson Disease; Sleep

1978
Bromocriptine in Parkinson's disease.
    Lancet (London, England), 1978, Jun-10, Volume: 1, Issue:8076

    Topics: Antiparkinson Agents; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease

1978
Tests of prolactin secretion in diagnosis of prolactinomas.
    Lancet (London, England), 1979, Jun-02, Volume: 1, Issue:8127

    Topics: Adolescent; Adult; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Metoclopramide; Paraneoplastic Endocrine Syndromes; Pituitary Function Tests; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Stimulation, Chemical; Thyrotropin-Releasing Hormone

1979
Chronic autonomic failure with postural hypotension.
    Lancet (London, England), 1979, Aug-25, Volume: 2, Issue:8139

    Topics: Autonomic Nervous System; Blood Pressure; Bromocriptine; Cardiovascular System; Chronic Disease; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Nerve Degeneration; Nervous System Diseases; Pressoreceptors

1979
Prolactin and the encephalopathy of Reye's syndrome.
    Lancet (London, England), 1979, Nov-24, Volume: 2, Issue:8152

    Topics: Bromocriptine; Cerebral Ventricles; Child; Dopamine; Epinephrine; Female; Hepatic Encephalopathy; Humans; Hypothalamus; Levodopa; Male; Norepinephrine; Prolactin; Reye Syndrome; Tyramine

1979
[The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)].
    Nihon Naibunpi Gakkai zasshi, 1978, May-20, Volume: 54, Issue:5

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Female; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Thyrotropin-Releasing Hormone

1978
Altered hypothalamic-pituitary function in uraemic patients [proceedings].
    The Journal of endocrinology, 1978, Volume: 79, Issue:2

    Topics: Adolescent; Adult; Bromocriptine; Female; Gonadotropins, Pituitary; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Metoclopramide; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Uremia

1978
Behavioral evidence for supersensitivity after chronic bromocriptine administration.
    Psychopharmacology, 1979, Feb-28, Volume: 60, Issue:3

    Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Drug Tolerance; Female; Humans; Levodopa; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Motor Activity; Receptors, Dopamine; Stereotyped Behavior

1979
Human pituitary adenomas with hypersecretion of TSH and prolactin. Evidence that receptor sites for dopamin may be absent on TSH producing while present on prolactin producing cells.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1979, Volume: 11, Issue:7

    Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Hyperthyroidism; Levodopa; Male; Pituitary Neoplasms; Prolactin; Receptors, Dopamine; Thyrotropin; Thyrotropin-Releasing Hormone

1979
The diagnostic value of pharmacodynamic tests in the hyperprolactinaemic syndrome.
    Clinical endocrinology, 1979, Volume: 11, Issue:2

    Topics: Adult; Bromocriptine; Chlorpromazine; Female; Follicular Phase; Galactorrhea; Humans; Levodopa; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin; Thyrotropin-Releasing Hormone

1979
Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
    Clinical endocrinology, 1979, Volume: 11, Issue:6

    Topics: Acromegaly; Aged; Animals; Bromocriptine; Dopamine; Drug Interactions; Female; Growth Hormone; Humans; Levodopa; Liver Cirrhosis; Male; Median Eminence; Middle Aged; Prolactin; Rats; Thyrotropin-Releasing Hormone; Time Factors

1979
Oscillations in performance in levodopa-treated parkinsonians: treatment with bromocriptine and L-deprenyl.
    Clinical and experimental neurology, 1979, Volume: 16

    Topics: Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Movement Disorders; Parkinson Disease; Phenethylamines; Selegiline

1979
Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Advances in biochemical psychopharmacology, 1977, Volume: 16

    Topics: Adult; Aged; Animals; Bromocriptine; Dextroamphetamine; Dopamine; Female; Growth Hormone; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Neural Pathways; Prolactin; Rats; Receptors, Dopamine; Time Factors

1977
Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
    Neuroendocrinology, 1979, Volume: 28, Issue:5

    Topics: Adult; Apomorphine; Bromocriptine; Female; Growth Hormone; Humans; Huntington Disease; Hypothalamo-Hypophyseal System; Levodopa; Male; Middle Aged; Receptors, Dopamine

1979
Modification of involuntary movements by centrally acting drugs.
    Advances in neurology, 1975, Volume: 9

    Topics: Aminooxyacetic Acid; Animals; Atropine; Bicuculline; Bromocriptine; Dopamine; Haloperidol; Haplorhini; Levodopa; Movement Disorders; Physostigmine; Picrotoxin; Piperazines; Piribedil; Receptors, Drug; Synaptic Transmission; Thalamic Nuclei; Theophylline

1975
Proposal of a new model with dopaminergic-cholinergic interactions for neuropharmacological investigations.
    Neuropsychobiology, 1975, Volume: 1, Issue:6

    Topics: Acetylcholine; Animals; Apomorphine; Atropine; Benserazide; Bromocriptine; Central Nervous System; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Haloperidol; Levodopa; Models, Neurological; Motor Activity; Physostigmine; Piribedil; Planarians; Reserpine; Synaptic Transmission; Turbellaria

1975
In practice. Parkinson's disease.
    The New Zealand medical journal, 1979, Oct-10, Volume: 90, Issue:645

    Topics: Amantadine; Basal Ganglia; Bromocriptine; Humans; Levodopa; Middle Aged; Movement; Parasympatholytics; Parkinson Disease; Prognosis; Synaptic Transmission

1979
Naloxone potentiation of 2-Br-alpha-ergocryptine (CB 154) effects on GH secretion in man.
    Neuroscience letters, 1979, Volume: 15, Issue:2-3

    Topics: Adult; Bromocriptine; Drug Synergism; Feedback; Growth Hormone; Humans; Levodopa; Male; Naloxone; Receptors, Dopamine; Receptors, Opioid

1979
Adenosine 3':5'-monophosphate-dependent in vitro phosphorylation of synaptosomal membrane proteins from rat corpus striatum following systemic administration of L-DOPA and bromocriptine.
    Neuroscience letters, 1979, Volume: 15, Issue:2-3

    Topics: Animals; Benserazide; Bromocriptine; Corpus Striatum; Cyclic AMP; In Vitro Techniques; Levodopa; Membrane Proteins; Phosphorylation; Rats; Stimulation, Chemical; Synaptic Membranes

1979
Opiates, prolactin, and the dopamine receptor.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:1

    Topics: Apomorphine; Bromocriptine; Chlorpromazine; Cyproheptadine; Heroin Dependence; Humans; Kinetics; Levodopa; Methadone; Morphine; Prolactin; Receptors, Dopamine

1978
Bromocriptine and parkinsonism.
    The New Zealand medical journal, 1978, Jun-28, Volume: 87, Issue:614

    Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease

1978
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.
    Psychiatry research, 1979, Volume: 1, Issue:3

    Topics: Adult; Bromocriptine; Carbidopa; Chronic Disease; Humans; Levodopa; Locus Coeruleus; Male; Meperidine; Opioid-Related Disorders; Parkinson Disease, Secondary; Substantia Nigra

1979
Functional delineation of hyperprolactinemic-amenorrhea.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:6

    Topics: Adenoma; Adult; Amenorrhea; Androgens; Bromocriptine; Dopamine; Estrogens; Female; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Humans; Hydrocortisone; Levodopa; Pituitary Neoplasms; Pregnancy; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone

1977
[Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment].
    La Clinica terapeutica, 1977, Aug-15, Volume: 82, Issue:3

    Topics: Acromegaly; Adult; Bromocriptine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Thyrotropin-Releasing Hormone

1977
Radioimmunoassay of thyrotrophin-releasing hormone (TRH) in normal subjects, in abnormal thyroid states and under catecholaminergic influences.
    Acta endocrinologica, 1978, Volume: 87, Issue:1

    Topics: Adenoma; Adult; Bromocriptine; Child; Chlorpromazine; Female; Humans; Hyperthyroidism; Hypothyroidism; Infant, Newborn; Levodopa; Male; Pituitary Neoplasms; Pregnancy; Radioimmunoassay; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1978
Parkinson's disease: search for better therapies.
    Science (New York, N.Y.), 1979, Feb-23, Volume: 203, Issue:4382

    Topics: Bromocriptine; Humans; Levodopa; Oligopeptides; Parkinson Disease; Receptors, Dopamine

1979
Long-term treatment of Parkinson's disease with bromocriptine.
    Journal of neurology, neurosurgery, and psychiatry, 1979, Volume: 42, Issue:2

    Topics: Adult; Age Factors; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1979
Hemiparkinsonism. A human model for studying dopaminergic supersensitivity.
    Archives of neurology, 1979, Volume: 36, Issue:4

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Dextroamphetamine; Disease Models, Animal; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease, Secondary; Receptors, Dopamine

1979
Drugs for parkinsonism.
    The Medical letter on drugs and therapeutics, 1979, May-04, Volume: 21, Issue:9

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1979
Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats.
    Life sciences, 1979, Apr-16, Volume: 24, Issue:16

    Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Corpus Striatum; Dyskinesia, Drug-Induced; Haloperidol; Levodopa; Male; Radioligand Assay; Rats; Receptors, Dopamine; Receptors, Drug; Spiperone

1979
Niacin depletion in Parkinsonian patients treated with L-dopa, benserazide and carbidopa.
    Clinical science (London, England : 1979), 1979, Volume: 56, Issue:1

    Topics: Adolescent; Adult; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Hydrazines; Levodopa; Male; Micrococcus; Middle Aged; Nicotinamidase; Nicotinic Acids; Parkinson Disease; Tryptophan

1979
In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:5

    Topics: Adenoma; Bromocriptine; Cells, Cultured; Dopamine; Growth Hormone; Humans; Levodopa; Pituitary Neoplasms; Prolactin

1979
EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study.
    Journal of neural transmission, 1979, Volume: 45, Issue:4

    Topics: Aged; Bromocriptine; Electroencephalography; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine; Reticular Formation; Sleep

1979
Plasma dopamine beta hydroxylase (D.B.H.) activity in Parkinsonian patients under L-dopa, and 2-bromo-alpha-ergocriptine loading.
    Journal of neural transmission, 1979, Volume: 46, Issue:1

    Topics: Bromocriptine; Dopamine beta-Hydroxylase; Humans; Kinetics; Levodopa; Parkinson Disease

1979
[Comparative action of L-dopa and bromocriptine on thyreostimulating hormone (T.S.H.) in primary hypothyroïdism (author's transl)].
    La Nouvelle presse medicale, 1979, Oct-08, Volume: 8, Issue:38

    Topics: Adult; Aged; Bromocriptine; Female; Humans; Hypothyroidism; Levodopa; Male; Middle Aged; Sex Factors; Thyrotropin; Time Factors

1979
The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality.
    Communications in psychopharmacology, 1977, Volume: 1, Issue:5

    Topics: Acetonitriles; Amphetamine; Animals; Behavior; Bromocriptine; Dopamine Antagonists; Drug Interactions; Ergolines; Fluphenazine; Humans; Levodopa; Male; Rats; Stereotyped Behavior

1977
The effect of levodopa, lergotrile, and bromocriptine on brain iron, manganese, and copper.
    Neurology, 1978, Volume: 28, Issue:7

    Topics: Acetonitriles; Animals; Brain Chemistry; Bromocriptine; Copper; Ergolines; Guinea Pigs; Iron; Levodopa; Male; Manganese; Metals

1978
Bromocriptine in Parkinson disease: further studies.
    Neurology, 1979, Volume: 29, Issue:3

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Evaluation; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1979
The role of bromocriptine in the treatment of parkinsonism.
    Neurology, 1979, Volume: 29, Issue:8

    Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1979
Activity of bromoergocryptine, Mucuna pruriens and L-dopa in the control of hyperprolactinaemia.
    Neurology India, 1978, Volume: 26, Issue:4

    Topics: Bromocriptine; Female; Galactorrhea; Humans; Lactation Disorders; Levodopa; Plants, Medicinal; Pregnancy; Prolactin

1978
Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
    Acta Europaea fertilitatis, 1978, Volume: 9, Issue:4

    Topics: Adult; Amenorrhea; Bromocriptine; Female; Follicle Stimulating Hormone; Galactorrhea; Humans; Levodopa; Luteinizing Hormone; Phenothiazines; Pregnancy; Prolactin

1978
The inhibitory effect of dopamine agonists on LH release in women.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:4

    Topics: Amenorrhea; Bromocriptine; Ergolines; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Prolactin

1977
Interaction between bromocriptine and levodopa. Biochemical basis for an improved treatment for parkinsonism.
    Neurology, 1977, Volume: 27, Issue:6

    Topics: Animals; Brain; Bromocriptine; Carbidopa; Dopamine; Drug Interactions; Ergolines; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Rats; Serotonin

1977
Treatment of Parkinson's disease with bromocriptine.
    The New England journal of medicine, 1977, Sep-01, Volume: 297, Issue:9

    Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease

1977
Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
    Acta endocrinologica, 1977, Volume: 86, Issue:2

    Topics: Adolescent; Adult; Bromocriptine; Ergolines; Female; Humans; Levodopa; Male; Metergoline; Pimozide; Prolactin; Sulpiride

1977
Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1977, Volume: 40, Issue:12

    Topics: Aged; Benserazide; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease

1977
The effect of dopaminergic drugs on pituitary hormone release in normal subjects.
    Acta medica Iugoslavica, 1977, Volume: 31, Issue:4

    Topics: Adult; Apomorphine; Bromocriptine; Chlorpromazine; Female; Humans; Levodopa; Pituitary Gland

1977
[Long-term administration of CB-154 in acromegaly].
    Horumon to rinsho. Clinical endocrinology, 1977, Volume: 25, Issue:12

    Topics: Acromegaly; Adult; Aged; Bromocriptine; Depression, Chemical; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged

1977
[Endocrinological aspects of the dopaminergic control of somatotropin in patients with acromegaly].
    Bollettino della Societa italiana di biologia sperimentale, 1977, Oct-15, Volume: 53, Issue:19

    Topics: Acromegaly; Adult; Bromocriptine; Female; Glycogen; Growth Hormone; Humans; Hydrocortisone; Insulin; Levodopa; Male; Middle Aged

1977
Dopamine receptor stimulation in the treatment of depression: piribedil (ET-495).
    Neuropsychobiology, 1978, Volume: 4, Issue:1

    Topics: Adjustment Disorders; Adult; Aged; Amphetamines; Anger; Antidepressive Agents; Bipolar Disorder; Bromocriptine; Depression; Female; Hostility; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Piperazines; Piribedil; Receptors, Dopamine; Syndrome

1978
Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs.
    Pharmacology, biochemistry, and behavior, 1978, Volume: 8, Issue:1

    Topics: Animals; Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Dopamine; Hydroxydopamines; Hypothalamus; Hypothalamus, Anterior; Levodopa; Male; Models, Neurological; Motor Activity; Norepinephrine; Piribedil; Rats; Receptors, Dopamine; Serotonin; Tyrosine

1978
A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine.
    Brain research, 1978, Jan-20, Volume: 140, Issue:1

    Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Carbidopa; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Male; Muscle Rigidity; Muscle Tonus; Myography; Rats; Reserpine

1978
Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias.
    British medical journal, 1978, Apr-15, Volume: 1, Issue:6118

    Topics: Aged; Benzimidazoles; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease

1978
Comparison between lergotrile and bromocriptine in parkinsonism.
    Annals of neurology, 1978, Volume: 3, Issue:4

    Topics: Acetonitriles; Adult; Aged; Bromocriptine; Carbidopa; Chemical Phenomena; Chemistry; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine

1978
Bromocriptine in parkinsonism. A long-term study.
    Archives of neurology, 1978, Volume: 35, Issue:8

    Topics: Anorexia; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease; Time Factors; Urinary Incontinence; Vasomotor System

1978
Prolactin clearance rates in male rats.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1978, Volume: 10, Issue:5

    Topics: Animals; Bromocriptine; Levodopa; Male; Metabolic Clearance Rate; Prolactin; Rats

1978
[Effect of L dopa, dopamine and CB 154 on prolactin secretion from human pituitary adenomas in vitro (proceedings) (author's transl)].
    Annales d'endocrinologie, 1978, Volume: 39, Issue:3

    Topics: Adenoma; Bromocriptine; Depression, Chemical; Dopamine; Humans; In Vitro Techniques; Levodopa; Pituitary Neoplasms; Prolactin

1978
Brain dopamine receptor stimulation and the relief of Parkinsonism: relationship between bromocriptine and levodopa.
    Annals of neurology, 1978, Volume: 4, Issue:3

    Topics: Benserazide; Brain; Bromocriptine; Female; Homovanillic Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine

1978
Bromocriptine in Parkinson's disease.
    British journal of hospital medicine, 1978, Volume: 20, Issue:6

    Topics: Bromocriptine; Humans; Levodopa; Parkinson Disease

1978
[Significance of blood levels of prolactin and somatotropin as indices of pharmacological effects on the central nervous system].
    La Clinica terapeutica, 1978, Jul-31, Volume: 86, Issue:2

    Topics: Adult; Brain; Bromocriptine; Growth Hormone; Humans; Levodopa; Male; Pharmacology; Phospholipids; Piracetam; Prolactin; Receptors, Dopamine

1978
Overview of present day treatment of Parkinson's disease.
    Journal of neural transmission, 1978, Volume: 43, Issue:3-4

    Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Phenethylamines; Receptors, Dopamine; Selegiline

1978
Bromocriptine in lieu of levodopa for Parkinson's disease.
    The Medical journal of Australia, 1978, Nov-04, Volume: 2, Issue:3 Suppl

    Topics: Adult; Aged; Bromocriptine; Humans; Levodopa; Middle Aged; Parkinson Disease

1978
[Prolactin and breast cancer].
    Pathologie-biologie, 1975, Volume: 23, Issue:10

    Topics: Adult; Animals; Breast Neoplasms; Bromocriptine; Carcinogens; Female; Humans; Lactation; Levodopa; Mice; Ovary; Pituitary Gland; Pregnancy; Prolactin; Rats

1975
Hypothalamic pituitary disorders expressed by galactorrhea. A dynamic evaluation.
    Obstetrics and gynecology, 1975, Volume: 46, Issue:5

    Topics: Amino Acids; Bromocriptine; Clomiphene; Female; Galactorrhea; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hypothalamo-Hypophyseal System; Insulin; Lactation Disorders; Levodopa; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Prolactin; Psychotropic Drugs; Stimulation, Chemical; Thyrotropin-Releasing Hormone; Water

1975
A neuropharmacological approach to experimental bruxism.
    Proceedings of the Finnish Dental Society. Suomen Hammaslaakariseuran toimituksia, 1977, Volume: 73, Issue:1

    Topics: Animals; Apomorphine; Behavior, Animal; Bromocriptine; Bruxism; Drug Synergism; Levodopa; Male; Mastication; Methylphenidate; Piribedil; Rats; Scopolamine; Theophylline; Time Factors

1977
Interelationships between dopaminergic and cholinergic systems in the cerebral cortex.
    Advances in biochemical psychopharmacology, 1977, Volume: 16

    Topics: Acetylcholine; Animals; Apomorphine; Benserazide; Bromocriptine; Cats; Cerebral Cortex; Dopamine; Female; Haloperidol; Levodopa; Male; Parasympathetic Nervous System; Rats; Time Factors

1977
Nonstriatal dopaminergic neurons: Section XI. Dopaminergic neurons and mental diseases: Introduction: dopaminergic neurons and mental diseases.
    Advances in biochemical psychopharmacology, 1977, Volume: 16

    Topics: Apomorphine; Bromocriptine; Catecholamines; Depression; Dopamine; Homovanillic Acid; Humans; Levodopa; Mental Disorders; Neurons; Schizophrenia

1977
[Combined therapy of parkinsonism with bromocriptine, L-dopa and decarboxylase inhibitor (author's transl)].
    Harefuah, 1977, Volume: 93, Issue:5-6

    Topics: Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease

1977
Brain dopamine turnover and the relief of parkinsonism.
    Advances in experimental medicine and biology, 1977, Volume: 90

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Parkinson Disease; Piperazines; Piribedil; Probenecid; Receptors, Dopamine

1977
Treatment of parkinsonism.
    Advances in experimental medicine and biology, 1977, Volume: 90

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Carbidopa; Dopamine; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine

1977
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.
    British journal of pharmacology, 1976, Volume: 56, Issue:1

    Topics: Amphetamine; Animals; Apomorphine; Bromocriptine; Drug Interactions; Ergolines; Humans; Hydroxydopamines; Levodopa; Male; Mice; Motor Activity; Rats; Receptors, Drug; Reserpine; Stereotyped Behavior; Substantia Nigra

1976
Pregnancy following 2-bromo-alpha-ergocryptine (CB-154)-induced ovulation in an acromegalic patient with galactorrhea and amenorrhea.
    Fertility and sterility, 1976, Volume: 27, Issue:3

    Topics: Acromegaly; Adult; Amenorrhea; Bromocriptine; Chorionic Gonadotropin; Female; Follicle Stimulating Hormone; Galactorrhea; Growth Hormone; Humans; Lactation Disorders; Levodopa; Luteinizing Hormone; Ovulation; Pregnancy; Pregnancy Complications; Prolactin

1976
Studies with bromocriptine. Part 1. "On-off" phenomena.
    Neurology, 1976, Volume: 26, Issue:6 PT 1

    Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1976
Comparison of reflex effects of levodopa and bromocriptine in Parkinsonism.
    British medical journal, 1976, Jul-24, Volume: 2, Issue:6029

    Topics: Bromocriptine; Ergolines; Humans; Levodopa; Parkinson Disease; Reflex

1976
Treatment of parkinson's disease with bromocriptine.
    The New England journal of medicine, 1976, Dec-16, Volume: 295, Issue:25

    Topics: Aged; Bromocriptine; Delusions; Dopa Decarboxylase; Drug Evaluation; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Parkinson Disease

1976
Growth hormone and prolactin release in acromegalic patients following metergoline administration.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:6

    Topics: Acromegaly; Adult; Animals; Bromocriptine; Ergolines; Growth Hormone; Humans; Levodopa; Male; Metergoline; Middle Aged; Prolactin; Serotonin; Serotonin Antagonists

1976
Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa.
    Journal of neurology, neurosurgery, and psychiatry, 1976, Volume: 39, Issue:11

    Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Follow-Up Studies; Growth Hormone; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parkinson Disease; Receptors, Dopamine

1976
Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
    Panminerva medica, 1975, Volume: 17, Issue:4

    Topics: Acromegaly; Amantadine; Bromocriptine; Ergolines; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phentolamine; Pituitary Gland; Propranolol

1975
Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
    IRCS journal of medical science, 1975, Volume: 3, Issue:6

    Topics: Adult; Bromocriptine; Ergolines; Female; Humans; Hypothalamus; Levodopa; Male; Metoclopramide; Pituitary Gland; Prolactin

1975
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
    Neuroendocrinology, 1975, Volume: 19, Issue:3

    Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil

1975
Editorial: Alternatives to levodopa.
    British medical journal, 1976, May-15, Volume: 1, Issue:6019

    Topics: Apomorphine; Bromocriptine; Humans; Levodopa; Parkinson Disease

1976
Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine.
    The American journal of the medical sciences, 1992, Volume: 304, Issue:5

    Topics: Adult; Bromocriptine; Calcium Channels; Growth Hormone; Humans; Kinetics; Levodopa; Male; Middle Aged; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Time Factors; Verapamil

1992
Postvaccinal parkinsonism.
    Movement disorders : official journal of the Movement Disorder Society, 1992, Volume: 7, Issue:2

    Topics: Bromocriptine; Child, Preschool; Dose-Response Relationship, Drug; Encephalomyelitis, Acute Disseminated; Humans; Levodopa; Magnetic Resonance Imaging; Male; Measles Vaccine; Neurologic Examination; Parkinson Disease, Postencephalitic; Substantia Nigra

1992
Dopamine agonists used as monotherapy in de novo PD patients: comparisons with selegiline.
    Neurology, 1992, Volume: 42, Issue:4 Suppl 4

    Topics: Bromocriptine; Clinical Trials as Topic; Dopamine Agents; Humans; Levodopa; Middle Aged; Parkinson Disease; Selegiline

1992
[Clozapine, a valuable contribution for the treatment of psychoses in Parkinson disease].
    Lakartidningen, 1992, Dec-02, Volume: 89, Issue:49

    Topics: Aged; Bromocriptine; Clozapine; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Psychoses, Substance-Induced

1992
No effect of chronic bromocriptine therapy on levodopa pharmacokinetics in patients with Parkinson's disease.
    Clinical neuropharmacology, 1992, Volume: 15, Issue:6

    Topics: Aged; Bromocriptine; Drug Interactions; Female; Half-Life; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1992
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
    Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 1992, Volume: 2, Issue:3

    Topics: Aged; Anthropometry; Body Composition; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Nutrition Assessment; Parkinson Disease; Reference Values; Sex Characteristics; Weight Loss

1992
Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:8

    Topics: Aged; Bromocriptine; Carbidopa; Combined Modality Therapy; Fabaceae; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Plants, Medicinal

1992
A component analysis of the generation and release of isometric force in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:7

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isometric Contraction; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Neurons; Muscles; Neurologic Examination; Parkinson Disease; Reaction Time; Trihexyphenidyl

1992
Reduced D2 dopamine and muscarinic cholinergic receptor densities in caudate specimens from fluctuating parkinsonian patients.
    Annals of neurology, 1991, Volume: 30, Issue:2

    Topics: Adult; Brain Tissue Transplantation; Bromocriptine; Caudate Nucleus; Down-Regulation; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Quinuclidinyl Benzilate; Receptors, Cholinergic; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, Neurotransmitter; Spiperone

1991
Cardiac beta-adrenoceptor sensitivity and Parkinson's disease.
    Fundamental & clinical pharmacology, 1991, Volume: 5, Issue:6

    Topics: Aged; Aging; Blood Pressure; Bromocriptine; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Isoproterenol; Levodopa; Male; Middle Aged; Myocardium; Parkinson Disease; Piribedil; Receptors, Adrenergic, beta

1991
[The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Nihon Naibunpi Gakkai zasshi, 1991, Feb-20, Volume: 67, Issue:2

    Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Hypothalamus; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin; Thyrotropin-Releasing Hormone

1991
Somatostatin-like immunoreactivity in the cerebrospinal fluid of aged patients with Parkinson's disease. The effect of dopatherapy.
    Journal of the American Geriatrics Society, 1990, Volume: 38, Issue:1

    Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Cognition Disorders; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Parkinson Disease; Severity of Illness Index; Somatostatin

1990
The influence of bromocriptine on the pharmacokinetics of levodopa in Parkinson's disease.
    Clinical neuropharmacology, 1991, Volume: 14, Issue:6

    Topics: Aged; Bromocriptine; Chromatography, High Pressure Liquid; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1991
Exteroceptive suppression of the masseter and temporalis muscles and parkinsonian rigidity.
    The Japanese journal of psychiatry and neurology, 1991, Volume: 45, Issue:4

    Topics: Adult; Aged; Amantadine; Basal Ganglia; Bromocriptine; Electric Stimulation; Electromyography; Female; Humans; Levodopa; Male; Masseter Muscle; Middle Aged; Muscle Rigidity; Muscle Spindles; Parkinson Disease; Temporal Muscle; Trigeminal Nerve; Trihexyphenidyl

1991
[Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
    Revista medica de Chile, 1991, Volume: 119, Issue:3

    Topics: Analysis of Variance; Bromocriptine; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone

1991
Pharmacological characteristics of catalepsy induced by intracerebroventricular administration of histamine in mice: the importance of muscarinic step in central cholinergic neurons.
    Agents and actions, 1991, Volume: 33, Issue:1-2

    Topics: Amantadine; Animals; Atropine; Biperiden; Bromocriptine; Catalepsy; Histamine; Injections, Intraventricular; Levodopa; Male; Mice; Neurons; Promethazine; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl

1991
Treating the progressive stages of Parkinson's disease.
    Postgraduate medicine, 1991, Volume: 90, Issue:1

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Pergolide; Selegiline

1991
Hyperprolactinemia in multiple sclerosis.
    Journal of the neurological sciences, 1991, Volume: 102, Issue:1

    Topics: Adult; Bromocriptine; Dopamine; Female; Galactorrhea; Humans; Hyperprolactinemia; Hypothalamus; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone

1991
Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient.
    Acta neurologica Scandinavica, 1991, Volume: 84, Issue:1

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Female; Gait; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Substance Withdrawal Syndrome

1991
Differential ability of selective and non-selective dopamine agonists to induce climbing in the rat indicates the involvement of both D-1 and D-2 receptors in this behaviour.
    Psychopharmacology, 1990, Volume: 100, Issue:1

    Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Bromocriptine; Clonidine; Dopamine Agents; Ergolines; Female; Levodopa; Motor Activity; Pergolide; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereotyped Behavior; Sulpiride

1990
Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile.
    European neurology, 1990, Volume: 30 Suppl 1

    Topics: Animals; Apomorphine; Autoradiography; Benzazepines; Brain Chemistry; Bromocriptine; Ceruletide; Dyskinesia, Drug-Induced; Levodopa; Male; Neurotoxins; Neurotransmitter Agents; Nitriles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Muscarinic

1990
Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists.
    European journal of pharmacology, 1990, Mar-13, Volume: 178, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autoradiography; Brain; Bromocriptine; Carbidopa; Catecholamines; Dopamine Agents; Female; Levodopa; Macaca fascicularis; Receptors, Dopamine; Spiperone

1990
Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up.
    Archives of neurology, 1990, Volume: 47, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benserazide; Bromocriptine; Child; Dopamine Agents; Drug Evaluation; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Nausea; Restless Legs Syndrome; Time Factors

1990
Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects.
    Journal of neurology, neurosurgery, and psychiatry, 1991, Volume: 54, Issue:2

    Topics: Administration, Oral; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease

1991
Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
    Clinical neuropharmacology, 1991, Volume: 14, Issue:1

    Topics: Aged; Blood Pressure; Bromocriptine; Epinephrine; Female; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Parkinson Disease; Posture

1991
Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
    Clinical and experimental neurology, 1990, Volume: 27

    Topics: Aged; Benserazide; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pulmonary Fibrosis; Serotonin

1990
A view from inside.
    British dental journal, 1990, Sep-22, Volume: 169, Issue:6

    Topics: Accidental Falls; Antiparkinson Agents; Bromocriptine; Carbidopa; Dentists; Drug Combinations; Humans; Levodopa; Male; Northern Ireland; Parkinson Disease

1990
Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393.
    European journal of pharmacology, 1990, Aug-28, Volume: 185, Issue:2-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Brain; Brain Chemistry; Bromocriptine; Dopamine; Female; Homovanillic Acid; Kinetics; Levodopa; Macaca fascicularis; Motor Activity; MPTP Poisoning; Parkinson Disease, Secondary; Receptors, Dopamine; Spiperone

1990
[The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Revue medicale de la Suisse romande, 1990, Volume: 110, Issue:6

    Topics: Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Parkinson Disease

1990
Bromocriptine blood levels after the concomitant administration of levodopa, amantadine and biperiden in Parkinson's disease.
    Acta neurologica Scandinavica, 1990, Volume: 81, Issue:5

    Topics: Administration, Oral; Aged; Amantadine; Biperiden; Bromocriptine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Piperidines

1990
Long-term effects of MPTP on central and peripheral catecholamine and indoleamine concentrations in monkeys.
    Brain research, 1986, Aug-06, Volume: 379, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Bromocriptine; Catecholamines; Chromatography, High Pressure Liquid; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Levodopa; Macaca fascicularis; Parkinson Disease, Secondary; Prolactin; Pyridines

1986
Parkinson disease: electrophysiological (CNV) analysis related to pharmacological treatment.
    Electroencephalography and clinical neurophysiology, 1986, Volume: 64, Issue:6

    Topics: Bromocriptine; Contingent Negative Variation; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Parkinson Disease

1986
Early dopamine agonist therapy in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 1989, Volume: 4 Suppl 1

    Topics: Antiparkinson Agents; Brain; Bromocriptine; Dopamine Agents; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine

1989
The influence of levodopa in the pharmacokinetics of bromocriptine in Parkinson's disease.
    Clinical neuropharmacology, 1989, Volume: 12, Issue:5

    Topics: Adjuvants, Pharmaceutic; Aged; Bromocriptine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1989
Second interim report of the nation-wide collaborative study on the long-term effects of bromocriptine in the treatment of parkinsonian patients.
    European neurology, 1989, Volume: 29 Suppl 1

    Topics: Adult; Aged; Aged, 80 and over; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1989
Falls and Parkinson's disease.
    Clinical neuropharmacology, 1989, Volume: 12, Issue:2

    Topics: Accidental Falls; Accidents; Aged; Bromocriptine; Female; Humans; Levodopa; Male; Parkinson Disease; Physical Therapy Modalities; Posture; Risk Factors

1989
Subcutaneous apomorphine in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:4

    Topics: Apomorphine; Bromocriptine; Drug Therapy, Combination; Humans; Injections, Subcutaneous; Levodopa; Middle Aged; Parkinson Disease

1989
Palilalia as a symptom of levodopa induced hyperkinesia in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1989, Volume: 52, Issue:6

    Topics: Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echolalia; Humans; Hyperkinesis; Levodopa; Male; Parkinson Disease

1989
[L-dopa, biperiden and sebum excretion in Parkinson disease].
    Arquivos de neuro-psiquiatria, 1989, Volume: 47, Issue:1

    Topics: Aged; Aged, 80 and over; Aromatic-L-Amino-Acid Decarboxylases; Biperiden; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines; Sebum; Sex Factors

1989
A community survey of Parkinson's disease.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1989, Sep-01, Volume: 141, Issue:5

    Topics: Aged; British Columbia; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Rural Population

1989
The effects on central dopamine function of chronic L-dopa (methyl ester hydrochloride) treatment of mice.
    Pharmacology, biochemistry, and behavior, 1989, Volume: 33, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Body Temperature; Bromocriptine; Dextroamphetamine; Dopamine; Levodopa; Mice; Mice, Inbred Strains; Motor Activity; Receptors, Dopamine; Stereotyped Behavior

1989
Dopamine receptors: applications in clinical cardiology.
    Circulation, 1985, Volume: 72, Issue:2

    Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopam; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Dopamine; Structure-Activity Relationship; Vascular Resistance

1985
Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.
    Psychopharmacology, 1985, Volume: 85, Issue:2

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Brain; Bromocriptine; Bupropion; Central Nervous System Stimulants; Cues; Generalization, Stimulus; Levodopa; Male; Nomifensine; Propiophenones; Rats; Receptors, Dopamine; Viloxazine

1985
Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.
    European archives of psychiatry and neurological sciences, 1985, Volume: 235, Issue:1

    Topics: Aged; Antipsychotic Agents; Benserazide; Bromocriptine; Clozapine; Delusions; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hallucinations; Humans; Hydrazines; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Tryptophan

1985
Effect of somatostatin and dopaminergic agents on bovine pituitary phosphodiesterase activity.
    Neuroendocrinology, 1986, Volume: 43, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Bromocriptine; Cattle; Dopamine; Kinetics; Levodopa; Pituitary Gland, Anterior; Pituitary Gland, Posterior; Somatostatin

1986
Parkinson's disease, depression, and the on-off phenomenon.
    Psychosomatics, 1989,Winter, Volume: 30, Issue:1

    Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease

1989
Comprehensive care of the patient with Parkinson's disease.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 1986, Volume: 18, Issue:3

    Topics: Aged; Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Male; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Patient Care Planning; Patient Care Team; Tremor

1986
Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin.
    The Journal of clinical endocrinology and metabolism, 1988, Volume: 66, Issue:2

    Topics: Acetylcholine; Adult; beta-Endorphin; beta-Lipotropin; Blood-Brain Barrier; Bromocriptine; Dexamethasone; Domperidone; Dopamine; Humans; Levodopa; Male; Metoclopramide; Nomifensine; Reference Values

1988
Increase of rat serum prolactin by adenosine analogs and their blockade by the methylxanthine aminophylline.
    Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 331, Issue:2-3

    Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); alpha-Methyltyrosine; Aminophylline; Animals; Bromocriptine; Corpus Striatum; Haloperidol; In Vitro Techniques; Levodopa; Male; Methyltyrosines; Phenylisopropyladenosine; Pituitary Gland, Anterior; Prolactin; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Receptors, Purinergic

1985
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment.
    European journal of clinical investigation, 1985, Volume: 15, Issue:6

    Topics: Aged; Blood Platelets; Bromocriptine; Cell Membrane; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Platelet Aggregation; Receptors, Adrenergic, alpha; Yohimbine

1985
Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 62, Issue:3

    Topics: Bromocriptine; Child; Child, Preschool; Dopamine; Estradiol; Female; Follicle Stimulating Hormone; Growth Disorders; Growth Hormone; Humans; Insulin-Like Growth Factor I; Levodopa; Luteinizing Hormone; Male; Testosterone; Thyroxine

1986
Function of dopamine receptors in Parkinson's disease: prolactin responses.
    Neurology, 1986, Volume: 36, Issue:3

    Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Receptors, Dopamine; Thyrotropin-Releasing Hormone; Time Factors

1986
Parkinson's disease in the elderly: a long-term efficacy study of levodopa/benserazide combination therapy.
    Pharmatherapeutica, 1986, Volume: 4, Issue:9

    Topics: Aged; Aged, 80 and over; Benserazide; Bromocriptine; Confusion; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Hydrazines; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease

1986
Current and future approaches to therapy.
    Advances in neurology, 1987, Volume: 45

    Topics: Antiparkinson Agents; Benserazide; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Selegiline

1987
Dopamine agonists as primary treatment in Parkinson's disease.
    Advances in neurology, 1987, Volume: 45

    Topics: Antiparkinson Agents; Bromocriptine; Disability Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Long-Term Care; Parkinson Disease; Pergolide; Receptors, Dopamine

1987
Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Advances in neurology, 1987, Volume: 45

    Topics: Aged; Bromocriptine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease

1987
Parkinson's disease in the elderly: current management strategies.
    Geriatrics, 1987, Volume: 42, Issue:7

    Topics: Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline

1987
In vivo and in vitro modulation of growth hormone and prolactin of a mixed somatotropic-lactotropic pituitary microadenoma.
    American journal of obstetrics and gynecology, 1987, Volume: 157, Issue:2

    Topics: Adenoma, Chromophobe; Adult; Bromocriptine; Chlorpromazine; Depression, Chemical; Female; Growth Hormone; Humans; In Vitro Techniques; Levodopa; Pituitary Neoplasms; Prolactin; Stimulation, Chemical; Thyrotropin-Releasing Hormone

1987
Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.
    Journal of endocrinological investigation, 1987, Volume: 10, Issue:4

    Topics: Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Hyperprolactinemia; Levodopa; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin

1987
Dynamics of growth hormone secretion in untreated acromegaly.
    The Journal of the Association of Physicians of India, 1987, Volume: 35, Issue:5

    Topics: Acromegaly; Adult; Bromocriptine; Female; Glucose Tolerance Test; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Levodopa; Male; Middle Aged; Thyrotropin-Releasing Hormone

1987
A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
    Bulletin of the Osaka Medical School, 1986, Volume: 32, Issue:2

    Topics: Aged; Alzheimer Disease; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamus; Kinetics; Levodopa; Male; Middle Aged; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone

1986
Milestones in the development of modern Parkinson therapy.
    Journal of neural transmission. Supplementum, 1987, Volume: 25

    Topics: 2,3-Diketogulonic Acid; Alloxan; Behavior; Bromocriptine; Drug Combinations; Drug Therapy, Combination; Ferric Compounds; Humans; Levodopa; Neurology; Parkinson Disease; Selegiline; Tryptophan

1987
Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Psychopharmacology, 1988, Volume: 94, Issue:1

    Topics: Aggression; Amphetamine; Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Imipramine; Levodopa; Male; Nomifensine; Rats; Rats, Inbred Strains; Sleep Deprivation; Sleep, REM; Stereotyped Behavior

1988
Drugs for parkinsonism.
    The Medical letter on drugs and therapeutics, 1988, Dec-16, Volume: 30, Issue:781

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Selegiline

1988
The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.
    International journal of clinical pharmacology, therapy, and toxicology, 1985, Volume: 23, Issue:4

    Topics: Adult; Aged; Apomorphine; Blood Pressure; Bromocriptine; Cardiovascular System; Catecholamines; Dopamine; Dopamine beta-Hydroxylase; Female; Heart Rate; Hemodynamics; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Parkinson Disease; Pulse; Sympathetic Nervous System

1985
Studies of the thyrotropic function of the adenopituitary of the offspring of rats treated during pregnancy with dopaminergic agents.
    Acta physiologica et pharmacologica Bulgarica, 1988, Volume: 14, Issue:3

    Topics: Animals; Bromocriptine; Female; Haloperidol; Levodopa; Male; Pituitary Gland, Anterior; Pregnancy; Rats; Rats, Inbred Strains; Thyrotropin

1988
[Emetic and catalepsy-inducing actions of buflomedil].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1988, Volume: 92, Issue:6

    Topics: Administration, Oral; Animals; Bromocriptine; Catalepsy; Dogs; Domperidone; Dose-Response Relationship, Drug; Levodopa; Male; Mice; Pyrrolidines; Vomiting

1988
Hypothalamo-pituitary dopaminergic system in patients with myotonic dystrophy.
    The Tohoku journal of experimental medicine, 1988, Volume: 156, Issue:3

    Topics: Adolescent; Adult; Bromocriptine; Dopamine; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Male; Middle Aged; Muscular Dystrophies; Prolactin; Sulpiride

1988
Early combination of dopamine agonist and levodopa in the treatment of Parkinson's disease.
    The Mount Sinai journal of medicine, New York, 1988, Volume: 55, Issue:2

    Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease

1988
International symposium on early dopamine agonist therapy of Parkinson's disease.
    Archives of neurology, 1988, Volume: 45, Issue:2

    Topics: Animals; Bromocriptine; Carbidopa; Dopamine; Humans; Levodopa; Parkinson Disease; Pergolide; Time Factors

1988
Lack of pharmacokinetic influence on levodopa by bromocriptine.
    Clinical neuropharmacology, 1988, Volume: 11, Issue:1

    Topics: Bromocriptine; Carbidopa; Chromatography, High Pressure Liquid; Drug Interactions; Female; Humans; Levodopa; Middle Aged; Parkinson Disease

1988
Bromocriptine therapy in striatonigral degeneration.
    Journal of neurology, neurosurgery, and psychiatry, 1988, Volume: 51, Issue:4

    Topics: Aged; Bromocriptine; Humans; Levodopa; Male; Nerve Degeneration; Parkinson Disease, Secondary; Putamen; Substantia Nigra

1988
Outpatient treatment of Parkinson's disease.
    European neurology, 1988, Volume: 28, Issue:3

    Topics: Ambulatory Care; Benserazide; Bromocriptine; Carboxy-Lyases; Drug Combinations; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Retrospective Studies

1988
[Nursing homes patients with Parkinson disease: treatment].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1988, Jun-20, Volume: 108, Issue:17-18

    Topics: Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Nursing Homes; Parkinson Disease

1988
Stepwise detoxification from cocaine. A promising regimen.
    Postgraduate medicine, 1988, Volume: 84, Issue:2

    Topics: Adolescent; Adult; Amantadine; Bromocriptine; Cocaine; Desipramine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Substance Withdrawal Syndrome; Substance-Related Disorders; Tryptophan; Tyrosine

1988
A pharmacological study of hibernation in rodents.
    General pharmacology, 1988, Volume: 19, Issue:4

    Topics: Adrenalectomy; Amphetamine; Animals; Bromocriptine; Cricetinae; Droxidopa; Epinephrine; Hibernation; Isoproterenol; Levodopa; Mesocricetus; Norepinephrine; Phenylephrine; Sciuridae

1988
Behavioral and biochemical evidence for a different effect of repeated administration of L-dopa and bromocriptine on denervated versus non-denervated striatal dopamine receptors.
    Neuropharmacology, 1987, Volume: 26, Issue:11

    Topics: Animals; Behavior, Animal; Benserazide; Bromocriptine; Corpus Striatum; Denervation; Female; In Vitro Techniques; Levodopa; Rats; Receptors, Dopamine; Spiperone

1987
[Akinetic mutism from recurrent hydrocephalus: successful treatment with levodopa, bromocriptine and trihexyphenidyl].
    No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:10

    Topics: Adult; Akinetic Mutism; Bromocriptine; Drug Therapy, Combination; Humans; Hydrocephalus; Levodopa; Male; Recurrence; Trihexyphenidyl

1987
The influence of dopamine agonists and antagonists on gastric lesions in mice.
    European journal of pharmacology, 1987, Dec-01, Volume: 144, Issue:2

    Topics: Animals; Bromocriptine; Dopamine Antagonists; Female; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C3H; Pylorus; Stomach Ulcer

1987
Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy.
    Bulletin of clinical neurosciences, 1986, Volume: 51

    Topics: Aged; Aged, 80 and over; Bromocriptine; Dose-Response Relationship, Drug; Drug Tolerance; Humans; Levodopa; Middle Aged; Parkinson Disease

1986
Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding.
    Brain research, 1986, Aug-06, Volume: 379, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Bromocriptine; Butyrophenones; Female; Kinetics; Levodopa; Macaca fascicularis; Movement Disorders; Parkinson Disease, Secondary; Pyridines; Spiperone; Time Factors

1986
MPTP toxicity: clinical features.
    Journal of neural transmission. Supplementum, 1986, Volume: 20

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Bromocriptine; California; Chemical Industry; District of Columbia; Female; Humans; Levodopa; Male; Occupational Diseases; Parkinson Disease, Secondary; Pyridines

1986
Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action.
    Clinical neuropharmacology, 1987, Volume: 10, Issue:4

    Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Receptors, Dopamine

1987
Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.
    Movement disorders : official journal of the Movement Disorder Society, 1987, Volume: 2, Issue:4

    Topics: Administration, Oral; Aged; Bromocriptine; Carbidopa; Cerebrovascular Circulation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Regional Blood Flow; Tomography, Emission-Computed

1987
Absence of growth hormone response to L-dopa and bromocriptine in hyperprolactinemic women with pituitary microadenoma.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 62, Issue:4

    Topics: Adenoma; Adult; Bromocriptine; Female; Growth Hormone; Humans; Hyperprolactinemia; Insulin; Levodopa; Pituitary Neoplasms

1986
[Antiparkinson agents].
    Nederlands tijdschrift voor geneeskunde, 1987, Feb-07, Volume: 131, Issue:6

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Lisuride; Parasympatholytics

1987
Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up.
    Neurology, 1987, Volume: 37, Issue:5

    Topics: Bromocriptine; Drug Therapy, Combination; Follow-Up Studies; Humans; Levodopa; Parkinson Disease

1987
[Bromocriptine and L-dopa therapy: comparison in a case of hereditary progressive dystonia with marked diurnal fluctuations].
    No to hattatsu = Brain and development, 1987, Volume: 19, Issue:3

    Topics: Adolescent; Bromocriptine; Dystonia; Female; Humans; Levodopa

1987
Excessive yawning and progressive supranuclear palsy.
    The International journal of neuroscience, 1987, Volume: 34, Issue:1-2

    Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Middle Aged; Supranuclear Palsy, Progressive; Yawning

1987
Ocular motor and manual tracking in Parkinson's disease and the effect of treatment.
    Journal of neurology, neurosurgery, and psychiatry, 1987, Volume: 50, Issue:7

    Topics: Adult; Aged; Bromocriptine; Eye Movements; Female; Hand; Humans; Levodopa; Male; Middle Aged; Movement; Parkinson Disease; Reaction Time; Saccades

1987
Optimum symptomatic control of Parkinson's disease with dopaminergic therapy.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:3 Suppl

    Topics: Aged; Bromocriptine; Drug Combinations; Humans; Levodopa; Middle Aged; Movement Disorders; Parkinson Disease; Time Factors

1987
Therapy of neuroleptic malignant syndrome.
    Psychiatric developments, 1986,Spring, Volume: 4, Issue:1

    Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine

1986
[Experience with the use of parlodel in the treatment of Parkinson patients].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986, Volume: 86, Issue:2

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Hypoxia, Brain; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary

1986
Bromocriptine: long-term low-dose therapy in Parkinson's disease.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:2

    Topics: Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Levodopa; Male; Middle Aged; Movement; Muscle Rigidity; Parkinson Disease; Tremor

1986
Pharmacotherapy: problems and practices.
    Clinical neuropharmacology, 1986, Volume: 9 Suppl 1

    Topics: Amantadine; Bromocriptine; Carbidopa; Drug Combinations; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1986
L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.
    Journal of clinical psychopharmacology, 1986, Volume: 6, Issue:3

    Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Interactions; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Serotonin

1986
Drugs for parkinsonism.
    The Medical letter on drugs and therapeutics, 1986, Jun-20, Volume: 28, Issue:716

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1986
Dystonia-Parkinson syndrome: differential effects of levodopa and dopamine agonists.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:3

    Topics: Adult; Bromocriptine; Carbidopa; Dystonia; Ergolines; Humans; Levodopa; Meige Syndrome; Middle Aged; Parkinson Disease; Pergolide; Torticollis

1986
[Revision of the treatment strategy in Parkinson disease].
    Nederlands tijdschrift voor geneeskunde, 1986, May-17, Volume: 130, Issue:20

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Patient Care Planning

1986
Synergistic effects of dopamine agonists and centrally administered neurotensin on feeding.
    Pharmacology, biochemistry, and behavior, 1986, Volume: 24, Issue:5

    Topics: Animals; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Eating; Hypothalamus; Injections; Injections, Intraventricular; Levodopa; Male; Neurotensin; Rats; Rats, Inbred Strains; Time Factors

1986
[Therapy of portosystemic encephalopathy].
    La Clinica terapeutica, 1986, May-31, Volume: 117, Issue:4

    Topics: Amino Acids, Branched-Chain; Ammonia; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Neomycin

1986
The drug treatment of parkinsonism.
    Scottish medical journal, 1986, Volume: 31, Issue:2

    Topics: Bromocriptine; Carboxy-Lyases; Dopamine; Humans; Levodopa; Parkinson Disease

1986
Management of Parkinson's disease in general practice.
    Scottish medical journal, 1986, Volume: 31, Issue:2

    Topics: Aged; Benserazide; Bromocriptine; Carbidopa; Drug Combinations; Family Practice; Humans; Levodopa; Medical Audit; Parkinson Disease

1986
Effect of antacid on levodopa therapy.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:5

    Topics: Aluminum Hydroxide; Bromocriptine; Carbidopa; Double-Blind Method; Drug Combinations; Drug Interactions; Humans; Levodopa; Magnesium; Magnesium Hydroxide; Parkinson Disease

1986
Alterations in [Met5]- and [Leu5]enkephalin and neurotensin content in basal ganglia induced by the long-term administration of dopamine agonist and antagonist drugs to rats.
    European journal of pharmacology, 1986, Nov-04, Volume: 130, Issue:3

    Topics: Animals; Basal Ganglia; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Enkephalin, Leucine; Enkephalin, Methionine; Levodopa; Male; Neurotensin; Pergolide; Rats; Rats, Inbred Strains; Trifluoperazine

1986
Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.
    The Journal of clinical endocrinology and metabolism, 1987, Volume: 64, Issue:2

    Topics: Acromegaly; Adult; Blood-Brain Barrier; Bromocriptine; Domperidone; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Prolactin; Sulpiride

1987
Selective regional effect of various neuroactive drugs on bromocriptine concentration in the brain of rats.
    Acta neurologica Scandinavica, 1986, Volume: 74, Issue:4

    Topics: Amantadine; Animals; Biperiden; Brain Chemistry; Bromocriptine; Carbidopa; Diazepam; Haloperidol; Levodopa; Methysergide; Naloxone; Rats

1986
Dopamine antagonists induce gastric lesions in rats.
    European journal of pharmacology, 1986, Nov-12, Volume: 131, Issue:1

    Topics: Animals; Bromocriptine; Domperidone; Dopamine Antagonists; Female; Haloperidol; Levodopa; Male; Metoclopramide; Rats; Rats, Inbred Strains; Stomach Ulcer

1986
[Combination treatment in the early stages of Parkinson's disease].
    Nordisk medicin, 1987, Volume: 102, Issue:1

    Topics: Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parasympatholytics; Parkinson Disease

1987
Low-dosage treatment in de novo patients with Parkinson's disease: a prospective study.
    Advances in neurology, 1987, Volume: 45

    Topics: Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Orphenadrine; Parkinson Disease

1987
Tracers for paralysis agitans in epidemiological research. IV. Trends in national drug policy and measurement of the prevalence of the disease in Sweden.
    Neuroepidemiology, 1985, Volume: 4, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Ambulatory Care; Antiparkinson Agents; Bromocriptine; Child; Child, Preschool; Drug Utilization; Epidemiologic Methods; Female; Humans; Infant; Infant Mortality; Levodopa; Male; Middle Aged; Parkinson Disease; Probability; Sweden; Time Factors

1985
Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
    Brain research, 1985, Sep-09, Volume: 342, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C57BL; Nomifensine; Pyridines

1985
Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism.
    Neuroscience letters, 1985, Aug-30, Volume: 59, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Biogenic Amines; Brain Chemistry; Bromocriptine; Female; Levodopa; Macaca fascicularis; Male; Motor Activity; Movement; Parkinson Disease, Secondary; Pyridines

1985
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
    Naunyn-Schmiedeberg's archives of pharmacology, 1985, Volume: 331, Issue:1

    Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine

1985
[Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
    Revista medica de Chile, 1985, Volume: 113, Issue:4

    Topics: Adolescent; Adult; Blood Glucose; Bromocriptine; Female; Growth Hormone; Humans; Hypothyroidism; Insulin; Levodopa; Male; Middle Aged; Prolactin

1985
Parkinson disease. Individualizing therapy.
    Hospital practice (Office ed.), 1985, Jan-15, Volume: 20, Issue:1

    Topics: Aged; Bromocriptine; Carbidopa; Central Nervous System Diseases; Diagnosis, Differential; Gait; Humans; Levodopa; Male; Motor Activity; Parkinson Disease; Psychoses, Substance-Induced; Tremor

1985
Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 61, Issue:3

    Topics: Age Determination by Skeleton; Bromocriptine; Child, Preschool; Estradiol; Female; Fetal Growth Retardation; Follicle Stimulating Hormone; Growth Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Levodopa; Luteinizing Hormone; Male; Pregnancy; Somatomedins; Testosterone; Thyrotropin; Thyroxine

1985
[Effect of dopaminergic pharmacological agents on thyrotropic hormone secretion by the hypophysis when stimulated with thyrotropin-releasing hormone].
    Eksperimentalna meditsina i morfologiia, 1985, Volume: 24, Issue:1

    Topics: Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Dopamine Antagonists; Haloperidol; Levodopa; Male; Pituitary Gland; Rats; Thyrotropin; Thyrotropin-Releasing Hormone

1985
Gigantism associated with McCune-Albright's syndrome.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1985, Volume: 17, Issue:10

    Topics: Adolescent; Bromocriptine; Fibrous Dysplasia of Bone; Fibrous Dysplasia, Polyostotic; Gigantism; Growth Hormone; Humans; Levodopa; Male; Radiography; Radionuclide Imaging; Thyrotropin-Releasing Hormone

1985
Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Methods and findings in experimental and clinical pharmacology, 1985, Volume: 7, Issue:8

    Topics: Apomorphine; Bromocriptine; Growth Hormone; Homovanillic Acid; Humans; Levodopa; Male; Metoclopramide; Monitoring, Physiologic; Neurosecretory Systems; Prolactin; Receptors, Dopamine; Schizophrenia; Selegiline; Time Factors

1985
Parathyroid hormone and calcitonin secretion in man: effect of dopamine agonists and antagonists.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1986, Volume: 18, Issue:1

    Topics: Adult; Bromocriptine; Calcitonin; Chlorpromazine; Dopamine; Dopamine Antagonists; Humans; Levodopa; Male; Metoclopramide; Middle Aged; Parathyroid Hormone; Prolactin

1986
[Dopaminergic agonists in Parkinson disease].
    La Revue du praticien, 1986, Jan-21, Volume: 36, Issue:5

    Topics: Aged; Bromocriptine; Dopamine; Ergolines; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Piribedil

1986
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
    Neurology, 1985, Volume: 35, Issue:2

    Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine

1985
Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
    Clinical neuropharmacology, 1985, Volume: 8, Issue:1

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1985
[Dopamine agonists in the therapy of parkinson syndrome].
    Der Nervenarzt, 1985, Volume: 56, Issue:2

    Topics: Animals; Antiparkinson Agents; Binding, Competitive; Bromocriptine; Corpus Striatum; Dopamine; Humans; Levodopa; Lisuride; Neural Pathways; Parkinson Disease; Piribedil; Receptors, Dopamine; Substantia Nigra

1985
Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease.
    Acta neurologica Scandinavica, 1985, Volume: 71, Issue:2

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Disability Evaluation; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease

1985
Idiopathic dystonia-parkinsonism with marked diurnal fluctuation of symptoms.
    Annals of neurology, 1985, Volume: 17, Issue:1

    Topics: Adult; Bromocriptine; Electromyography; Electrophysiology; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Trihexyphenidyl

1985
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide.
    Neurology, 1985, Volume: 35, Issue:5

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Hallucinations; Humans; Levodopa; Male; Middle Aged; Nausea; Outcome and Process Assessment, Health Care; Parkinson Disease; Pergolide; Time Factors

1985
Three-year observation of mesulergine (CU 32-085) in advanced and newly treated parkinsonism.
    Journal of neurology, 1985, Volume: 232, Issue:1

    Topics: Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1985
[Clinical significance of long-term treatment of L-dopa with bromocriptine in parkinsonian patients who showed declining efficacy during L-dopa therapy].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1985, Volume: 74, Issue:3

    Topics: Adult; Aged; Bromocriptine; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1985
[Hyperprolactinemia and ovulatory dysfunction].
    Zhonghua fu chan ke za zhi, 1985, Volume: 20, Issue:3

    Topics: Adult; Anovulation; Bromocriptine; Female; Humans; Levodopa; Pituitary Neoplasms; Prolactin

1985
The role of dopamine in the formation of gastric ulcers in rats.
    European journal of pharmacology, 1985, May-28, Volume: 112, Issue:1

    Topics: Animals; Apomorphine; Bromocriptine; Domperidone; Dopamine; Female; Haloperidol; Levodopa; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Sulpiride

1985
[Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Medicina clinica, 1985, Jun-15, Volume: 85, Issue:3

    Topics: Age Factors; Aged; Amantadine; Antidepressive Agents, Tricyclic; Aromatic Amino Acid Decarboxylase Inhibitors; Bromocriptine; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease

1985
Combined bromocriptine-levodopa therapy early in Parkinson's disease.
    Neurology, 1985, Volume: 35, Issue:8

    Topics: Bromocriptine; Disability Evaluation; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1985
The treatment of Parkinson's disease.
    The Medical journal of Australia, 1985, Oct-14, Volume: 143, Issue:8

    Topics: Aged; Bromocriptine; Carboxy-Lyases; Humans; Levodopa; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced

1985
Pain in Parkinson's disease.
    Pain, 1985, Volume: 22, Issue:4

    Topics: Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Pain; Parkinson Disease

1985
Controversies in the treatment of Parkinson's disease.
    Rational drug therapy, 1985, Volume: 19, Issue:2

    Topics: Bromocriptine; Humans; Levodopa; Movement Disorders; Parkinson Disease; Time Factors

1985
[Oral lisuride in Parkinson's disease].
    Medicina clinica, 1985, Sep-21, Volume: 85, Issue:8

    Topics: Adult; Aged; Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease

1985
Treatment of parkinsonism with bromocriptine.
    Lancet (London, England), 1974, Dec-07, Volume: 2, Issue:7893

    Topics: Bromocriptine; Drug Evaluation; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Parkinson Disease

1974
Original articles.
    The Netherlands journal of medicine, 1974, Volume: 17, Issue:4-5

    Topics: Adenoma, Chromophobe; Adolescent; Adult; Aged; Bromocriptine; Female; Humans; Hypoglycemia; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Radioimmunoassay

1974
Dopamine agonists and Parkinson's disease.
    Clinical neurology and neurosurgery, 1984, Volume: 86, Issue:3

    Topics: Antiparkinson Agents; Apomorphine; Brain; Bromocriptine; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Neurons; Parkinson Disease; Pergolide; Piribedil; Receptors, Dopamine

1984
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile.
    British journal of clinical pharmacology, 1980, Volume: 9, Issue:1

    Topics: Aged; Blood Pressure; Bromocriptine; Drug Tolerance; Ergolines; Heart Rate; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1980
Release of somatostatin and thyrotropin-releasing hormone from rat hypothalamic fragments in vitro.
    Endocrinology, 1980, Volume: 106, Issue:6

    Topics: Animals; Bromocriptine; Bucladesine; Calcium; Dopamine; Haloperidol; Hypothalamus; In Vitro Techniques; Levodopa; Male; Neurotransmitter Agents; Potassium; Rats; Somatostatin; Thyrotropin-Releasing Hormone; Veratridine

1980
Bromocriptine in treatment of levodopa-induced end-of-dose dystonia.
    Lancet (London, England), 1980, Jul-26, Volume: 2, Issue:8187

    Topics: Bromocriptine; Dystonia; Female; Humans; Levodopa; Middle Aged; Parkinson Disease

1980
Hepatic encephalopathy.
    The Medical clinics of North America, 1981, Volume: 65, Issue:1

    Topics: Amino Acids; Ammonia; Bromocriptine; Constipation; Dietary Proteins; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Infections; Kidney Diseases; Lactulose; Levodopa; Liver Diseases; Neomycin; Neurotransmitter Agents

1981
Bromocriptine for levodopa-induced end-of-dose dystonia.
    Lancet (London, England), 1981, Mar-14, Volume: 1, Issue:8220 Pt 1

    Topics: Aged; Bromocriptine; Dystonia; Female; Humans; Levodopa; Parkinson Disease

1981
The functional role of the noradrenergic neurons in the thermoregulatory circuits in mice.
    Journal of neural transmission, 1981, Volume: 50, Issue:2-4

    Topics: Animals; Antipsychotic Agents; Apomorphine; Biogenic Amines; Body Temperature Regulation; Brain; Bromocriptine; Female; Hydroxydopamines; Kinetics; Levodopa; Male; Mice; Mice, Inbred Strains; Neurons; Norepinephrine; Piribedil

1981
Akinetic mutism from hypothalamic damage: successful treatment with dopamine agonists.
    Neurology, 1981, Volume: 31, Issue:11

    Topics: Adult; Akinetic Mutism; Bromocriptine; Carbidopa; Ergolines; Humans; Hypothalamic Neoplasms; Hypothalamus; Levodopa; Male; Methylphenidate; Postoperative Complications

1981
Low CSF GABA in Parkinsonian patients who respond poorly to therapy or suffer from the "on-off" phenomenon.
    Annals of neurology, 1982, Volume: 11, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Ergolines; Female; gamma-Aminobutyric Acid; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prognosis; Radioligand Assay

1982
[Drug therapy of parkinsonism].
    Duodecim; laaketieteellinen aikakauskirja, 1982, Volume: 98, Issue:11

    Topics: Amantadine; Bromocriptine; Dopamine Antagonists; Humans; Levodopa; Neurotransmitter Agents; Parasympatholytics; Parkinson Disease

1982
Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    The Journal of clinical investigation, 1984, Volume: 73, Issue:1

    Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cells, Cultured; Dopamine; Endorphins; Female; Growth Hormone; Haloperidol; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Pituitary Gland; Pituitary Neoplasms; Prolactin; Somatostatin; Thyrotropin-Releasing Hormone

1984
Treatments for neuroleptic malignant syndrome.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:3

    Topics: Adult; Amantadine; Antipsychotic Agents; Bromocriptine; Catatonia; Electroconvulsive Therapy; Fever; Humans; Levodopa; Male

1984
[Hepatic coma. Therapeutic aspects].
    Minerva medica, 1984, Aug-25, Volume: 75, Issue:32-33

    Topics: Amino Acids; Bromocriptine; Electrolytes; Furosemide; Glucose; Hepatic Encephalopathy; Histamine H2 Antagonists; Humans; Infusions, Parenteral; Levodopa; Nitrogen; Spironolactone; Vitamin B Complex

1984
Long-term experience with bromocriptine in advanced parkinsonism. Results after one year's treatment.
    Journal of neurology, 1982, Volume: 228, Issue:4

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Parkinson Disease

1982
[Therapeutic concept in Parkinson disease].
    Deutsche medizinische Wochenschrift (1946), 1983, Jul-15, Volume: 108, Issue:28-29

    Topics: Adrenergic beta-Antagonists; Amantadine; Antidepressive Agents, Tricyclic; Benzodiazepines; Bromocriptine; Depression; Fludrocortisone; Humans; Hypotension, Orthostatic; Levodopa; Midodrine; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Thalamus; Tremor

1983
Therapeutic experience with the new dopamine agonist CU 32-085 in advanced Parkinson's disease.
    Journal of neurology, 1983, Volume: 230, Issue:1

    Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parasympatholytics; Parkinson Disease

1983
Dopamine agonists in Parkinson's disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl

    Topics: Bromocriptine; Dopamine; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Humans; Levodopa; Lisuride; Parkinson Disease; Pergolide; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2

1984
Dopamine agonists in the treatment of Parkinson's disease.
    Advances in neurology, 1983, Volume: 37

    Topics: Blood Pressure; Bromocriptine; Disability Evaluation; Domperidone; Dopamine; Ergolines; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Pleural Effusion; Receptors, Neurotransmitter; Time Factors

1983
Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.
    Journal of neural transmission. Supplementum, 1983, Volume: 18

    Topics: Apomorphine; Brain; Bromocriptine; Humans; Levodopa; Parkinson Disease; Prolactin; Receptors, Dopamine; Receptors, Opioid; Thyrotropin-Releasing Hormone

1983
Combined administration of direct dopamine receptor agonists and L-dopa does not interfere with utilization of exogenous L-dopa in rat corpus striatum.
    Progress in neuro-psychopharmacology & biological psychiatry, 1983, Volume: 7, Issue:2-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Levodopa; Male; Muridae; Receptors, Dopamine; Synaptic Transmission

1983
Comparison of single and combined tests for the evaluation of plasma growth hormone secretion in normal short children.
    Journal of endocrinological investigation, 1984, Volume: 7, Issue:4

    Topics: Adolescent; Body Height; Bromocriptine; Child; False Negative Reactions; Growth Hormone; Humans; Hypoglycemia; Insulin; Levodopa; Physical Exertion; Propranolol

1984
Dopaminergic regulation of prolactin secretion in the hyperprolactinemic syndrome.
    Gynecologic and obstetric investigation, 1983, Volume: 16, Issue:2

    Topics: Adenoma; Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Humans; Levodopa; Luteinizing Hormone; Pituitary Gland; Pituitary Neoplasms; Prolactin; Radiography; Syndrome

1983
Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    The Journal of clinical endocrinology and metabolism, 1984, Volume: 58, Issue:3

    Topics: Age Determination by Skeleton; Bromocriptine; Child; Child, Preschool; Estradiol; Female; Follicle Stimulating Hormone; Growth Disorders; Growth Hormone; Humans; Hydrocortisone; Insulin-Like Growth Factor I; Levodopa; Luteinizing Hormone; Male; Somatomedins; Testosterone; Thyrotropin; Thyroxine

1984
Adjuvant drugs in the treatment of on-off phenomena in Parkinson's disease.
    Advances in neurology, 1984, Volume: 40

    Topics: Benzamides; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Phenethylamines; Selegiline; Tiapamil Hydrochloride

1984
Human growth hormone and dopaminergic drugs, with special reference to deprenyl (selegiline): a summary of studies on volunteers.
    Acta neurologica Scandinavica. Supplementum, 1983, Volume: 95

    Topics: Apomorphine; Bromocriptine; Dopamine; gamma-Aminobutyric Acid; Growth Hormone; Humans; Levodopa; Phenethylamines; Receptors, Dopamine; Selegiline; Synapses

1983
Therapy of neurologic disorders in the elderly.
    Hospital practice (Office ed.), 1984, Volume: 19, Issue:10

    Topics: Aged; Amantadine; Anticoagulants; Brain Ischemia; Bromocriptine; Carbidopa; Dexamethasone; Drug Interactions; Heparin; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Trihexyphenidyl

1984
Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
    Clinical neuropharmacology, 1984, Volume: 7, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Hydroxydopamines; Kinetics; Levodopa; Male; Membranes; Oxidopamine; Parkinson Disease; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone; Stereotyped Behavior; Substantia Nigra

1984
Effect of l-dopa or bromocriptine on feeding and motor behavior of rats with lesions in the globus pallidus.
    Physiology & behavior, 1984, Volume: 33, Issue:2

    Topics: Animals; Body Weight; Brain Mapping; Bromocriptine; Carbidopa; Drinking; Eating; Globus Pallidus; Hydroxydopamines; Levodopa; Male; Motor Activity; Neural Pathways; Oxidopamine; Rats; Receptors, Dopamine; Sex Factors

1984
[Attempted direct etiological treatment of Huntington's chorea. Case reports].
    Minerva medica, 1980, Apr-21, Volume: 71, Issue:16

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Haloperidol; Humans; Huntington Disease; Levodopa; Middle Aged; Piperazines; Piribedil

1980
[Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
    Revue neurologique, 1981, Volume: 137, Issue:1

    Topics: Adolescent; Adult; Arginine; Bromocriptine; Female; Glucose Tolerance Test; Growth Hormone; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Receptors, Dopamine; Stimulation, Chemical; Time Factors

1981
Effect of various neuroactive drugs on bromocriptine concentration in the striatum of rats.
    Israel journal of medical sciences, 1984, Volume: 20, Issue:5

    Topics: Animals; Bromocriptine; Central Nervous System Agents; Corpus Striatum; Levodopa; Naloxone; Nervous System; Rats

1984
The drug treatment of Parkinson's disease.
    Australian family physician, 1984, Volume: 13, Issue:5 Suppl

    Topics: Amantadine; Bromocriptine; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Levodopa; Nausea; Parasympatholytics; Parkinson Disease

1984
Bromocriptine in the management of end of dose deterioration in Parkinson's disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:4

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Nausea; Parkinson Disease

1984
Severity of Parkinson's disease and the dosage of bromocriptine.
    Neurology, 1984, Volume: 34, Issue:6

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Retrospective Studies

1984
Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
    Neurology, 1983, Volume: 33, Issue:4

    Topics: Activities of Daily Living; Adult; Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Middle Aged; Nausea; Parkinson Disease; Psychomotor Performance; Receptors, Dopamine

1983
Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.
    Pharmacopsychiatria, 1983, Volume: 16, Issue:4

    Topics: Benserazide; Bromocriptine; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sexual Dysfunction, Physiological

1983
Therapeutic results with a new ergoline derivate (8-alpha-amino-ergoline, CU 32-085) in parkinsonian patients.
    Advances in neurology, 1984, Volume: 40

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1984
Bromocriptine and lisuride in Parkinson's disease.
    Advances in neurology, 1984, Volume: 40

    Topics: Adult; Aged; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Ergolines; Female; Humans; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease

1984
Clinical administration of parlodel in low doses.
    Advances in neurology, 1984, Volume: 40

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1984
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl

    Topics: Adult; Aged; Bromocriptine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors

1984
Should dopamine agonists be given early or late? A review of nine years experience with bromocriptine.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1984, Volume: 11, Issue:1 Suppl

    Topics: Aged; Bromocriptine; Drug Evaluation; Humans; Levodopa; Middle Aged; Parkinson Disease; Retrospective Studies; Time Factors

1984
Diagnosis and management of Parkinson's disease.
    Geriatrics, 1984, Volume: 39, Issue:5

    Topics: Bromocriptine; Diagnosis, Differential; Humans; Levodopa; Muscle Rigidity; Parasympatholytics; Parkinson Disease; Tremor

1984
Long-term efficacy of bromocriptine in Parkinson disease.
    Neurology, 1980, Volume: 30, Issue:5

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Levodopa; Long-Term Care; Middle Aged; Parkinson Disease; Substance Withdrawal Syndrome

1980
Normal pituitary function and reserve after selective transsphenoidal removal of a thyrotropin-producing pituitary adenoma.
    Metabolism: clinical and experimental, 1980, Volume: 29, Issue:8

    Topics: Adenoma; Adult; Bromocriptine; Female; Humans; Levodopa; Metoclopramide; Microsurgery; Pituitary Gland; Pituitary Neoplasms; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine

1980
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
    Progress in clinical and biological research, 1980, Volume: 39

    Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor

1980
The use of bromocriptine for testing central dopaminergic reactivity.
    Psychopharmacology, 1980, Volume: 70, Issue:3

    Topics: Blood Pressure; Brain; Bromocriptine; Drug Resistance; Humans; Levodopa; Movement Disorders; Parkinson Disease; Receptors, Dopamine; Renin

1980
Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
    Acta medica Scandinavica, 1981, Volume: 209, Issue:5

    Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Bromocriptine; Diagnosis, Differential; Empty Sella Syndrome; Female; Humans; Levodopa; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Thyrotropin-Releasing Hormone

1981
Thyrotropin-releasing hormone, chlorpromazine and L-dopa or bromocriptin tests in Cushing's syndrome due to adrenal hyperplasia and adrenal adenoma.
    Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1981, Volume: 80, Issue:1

    Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Bromocriptine; Chlorpromazine; Cushing Syndrome; Female; Humans; Hyperplasia; Levodopa; Prolactin; Thyrotropin-Releasing Hormone

1981
The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
    Psychopharmacology, 1982, Volume: 78, Issue:1

    Topics: Animals; Apomorphine; Bromocriptine; Butyrophenones; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Humans; Levodopa; Male; Muridae; Receptors, Dopamine; Spiperone; Stereotyped Behavior

1982
Bromocriptine and lisuride in Parkinson disease.
    Annals of neurology, 1983, Volume: 13, Issue:1

    Topics: Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Lisuride; Middle Aged; Parkinson Disease

1983
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
    Advances in neurology, 1983, Volume: 37

    Topics: Aged; Bromocriptine; Disability Evaluation; Drug Evaluation; Ergolines; Humans; Levodopa; Middle Aged; Parkinson Disease; Pergolide; Time Factors

1983
[Bromocriptine (Parlodel) in the treatment of Parkinson's disease. Summary of 7 years' experience].
    Revue medicale de Liege, 1983, May-01, Volume: 38, Issue:9

    Topics: Bromocriptine; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1983
Recent advances in the treatment of Parkinson's disease.
    Acta neurologica Scandinavica. Supplementum, 1980, Volume: 78

    Topics: Brain; Bromocriptine; Drug Therapy, Combination; Endorphins; Enkephalins; Humans; Levodopa; Mental Disorders; Parkinson Disease; Receptors, Dopamine

1980
Differential effects of dopamine agonists in mature and immature rats.
    European journal of pharmacology, 1981, Jun-10, Volume: 72, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Animals, Newborn; Apomorphine; Benzazepines; Bromocriptine; Dextroamphetamine; Dopamine; Female; Humans; Levodopa; Male; Motor Activity; Rats; Scopolamine; Stereotyped Behavior; Sympathomimetics

1981
[Bromocriptine in the treatment of patients with parkinsonism and dyskinesias induced by levodopa].
    Nederlands tijdschrift voor geneeskunde, 1982, Apr-17, Volume: 126, Issue:16

    Topics: Adult; Aged; Bromocriptine; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1982
[Idiopathic edema].
    Nihon rinsho. Japanese journal of clinical medicine, 1982, Volume: 40, Issue:3

    Topics: Adult; Bromocriptine; Capillary Permeability; Edema; Female; Humans; Levodopa; Male

1982
Hyperprolactinemia and sexual disorders in men.
    Biological psychiatry, 1982, Volume: 17, Issue:8

    Topics: Bromocriptine; Drive; Ejaculation; Erectile Dysfunction; Humans; Levodopa; Libido; Male; Prolactin; Sex Education; Testosterone

1982
Initial treatment of Parkinson's disease.
    Clinical neuropharmacology, 1982, Volume: 5 Suppl 1

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Administration Schedule; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Prognosis

1982
Behavioral alterations and the therapy of parkinsonism.
    Clinical neuropharmacology, 1982, Volume: 5 Suppl 1

    Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced

1982
Bromocriptine combined with levodopa in Parkinson's disease.
    European neurology, 1982, Volume: 21, Issue:4

    Topics: Aged; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Motor Skills; Parkinson Disease

1982
Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.
    Clinical neuropharmacology, 1982, Volume: 5, Issue:2

    Topics: Aged; Bromocriptine; Carbidopa; Dreams; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Sleep Stages

1982
Prolactin-secreting pituitary adenoma: occurrence following prenatal exposure to diethylstilbestrol.
    Cleveland Clinic quarterly, 1982,Winter, Volume: 49, Issue:4

    Topics: Adenoma; Adolescent; Bromocriptine; Chlorpromazine; Diethylstilbestrol; Female; Humans; Levodopa; Pituitary Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Prolactin

1982
Bilateral vocal cord paralysis in Parkinson's disease.
    Archives of otolaryngology (Chicago, Ill. : 1960), 1981, Volume: 107, Issue:4

    Topics: Aged; Bromocriptine; Carbidopa; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Tracheotomy; Vocal Cord Paralysis

1981
[Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Der Nervenarzt, 1981, Volume: 52, Issue:2

    Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1981
Method of addition of bromocriptine to the drug regime of patients with advanced Parkinson's disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1981, Volume: 8, Issue:1

    Topics: Aged; Bromocriptine; Carbidopa; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1981
[Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
    Revue neurologique, 1981, Volume: 137, Issue:1

    Topics: Aged; Aromatic Amino Acid Decarboxylase Inhibitors; Benzimidazoles; Bromocriptine; Domperidone; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piperidines

1981
Parkinson's disease: new treatments.
    Comprehensive therapy, 1981, Volume: 7, Issue:4

    Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus

1981
Bromocriptine and its use in Parkinsonism.
    Journal of the American Geriatrics Society, 1981, Volume: 29, Issue:6

    Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease

1981
Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide.
    Life sciences, 1981, May-11, Volume: 28, Issue:19

    Topics: Animals; Apomorphine; Bromocriptine; Levodopa; Male; Metoclopramide; Prolactin; Rats; Serotonin

1981
Treatment of Parkinson's disease: problems with a progressing disease.
    Journal of neural transmission, 1981, Volume: 51, Issue:1-2

    Topics: Bromocriptine; Follow-Up Studies; Humans; Levodopa; Parkinson Disease; Prognosis; Receptors, Dopamine

1981
Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
    The Journal of clinical endocrinology and metabolism, 1981, Volume: 53, Issue:6

    Topics: Acromegaly; Adenoma; Adult; Apomorphine; Breast Neoplasms; Bromocriptine; Cells, Cultured; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Sympathomimetics

1981
[Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism].
    Ugeskrift for laeger, 1981, Oct-05, Volume: 143, Issue:41

    Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Diseases

1981
A perplexing case of juvenile extrapyramidal disease.
    Italian journal of neurological sciences, 1981, Volume: 2, Issue:2

    Topics: Adolescent; Atrophy; Basal Ganglia Diseases; Bromocriptine; Electroencephalography; Female; Globus Pallidus; Humans; Levodopa; Parkinson Disease, Secondary; Tomography, X-Ray Computed

1981
"Long term evaluation of combined treatment of Parkinson disease with L-dopa, peripheral decarboxylase inhibitors and bromocreptine".
    Italian journal of neurological sciences, 1981, Volume: 2, Issue:4

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carboxy-Lyases; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic

1981
Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1981, Volume: 44, Issue:11

    Topics: Adult; Aged; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1981
[Crises in the course of Parkinson's disease].
    Wiener medizinische Wochenschrift (1946), 1980, Feb-29, Volume: 130, Issue:4

    Topics: Aged; Amantadine; Bromocriptine; Depression; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders

1980
Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women.
    Acta endocrinologica, 1980, Volume: 93, Issue:3

    Topics: Adult; Bromocriptine; Dopamine; Drug Interactions; Female; Humans; Levodopa; Luteinizing Hormone; Metergoline; Methysergide; Prolactin; Receptors, Dopamine; Serotonin; Serotonin Antagonists

1980
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Bromocriptine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Levodopa; Middle Aged; Parkinson Disease

1980
Further experiences with low doses of bromocriptine in Parkinson's disease.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Parkinson Disease

1980
Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Aged; Bromocriptine; Humans; Levodopa; Middle Aged; Parkinson Disease

1980
The role of bromocriptine in the treatment of Parkinson's disease.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Bromocriptine; Carbidopa; Dose-Response Relationship, Drug; Humans; Levodopa; Middle Aged; Parkinson Disease

1980
A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Advances in biochemical psychopharmacology, 1980, Volume: 23

    Topics: Adult; Aged; Bromocriptine; Carbidopa; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1980
The role of D-1 and D-2 receptors.
    Nature, 1980, Jul-10, Volume: 286, Issue:5769

    Topics: Adenylyl Cyclases; Bromocriptine; Growth Hormone; Humans; Levodopa; Lisuride; Metoclopramide; Parkinson Disease; Pimozide; Prolactin; Receptors, Dopamine

1980
Effects of L-dopa and bromocriptine on calcitonin secretion in medullary thyroid carcinoma.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 51, Issue:4

    Topics: Adolescent; Adult; Bromocriptine; Calcitonin; Carcinoma; Female; Humans; Kinetics; Levodopa; Male; Middle Aged; Pentagastrin; Thyroid Neoplasms

1980
[Current treatment of Parkinsonian syndrome].
    Die Medizinische Welt, 1980, Volume: 31, Issue:40

    Topics: Amantadine; Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Parkinson Disease, Secondary

1980
Lisuride in the treatment of Parkinsonism.
    Acta neurologica Scandinavica, 1980, Volume: 62, Issue:6

    Topics: Administration, Oral; Aged; Bromocriptine; Drug Therapy, Combination; Ergolines; Humans; Injections, Intravenous; Levodopa; Lisuride; Middle Aged; Parkinson Disease

1980
Treatment of Parkinson's disease.
    Australian family physician, 1995, Volume: 24, Issue:9

    Topics: Antiparkinson Agents; Bromocriptine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Pergolide; Prognosis; Selegiline

1995
Parkinsonian medication one hour before meals improves symptomatic swallowing: a case study.
    Dysphagia, 1995,Summer, Volume: 10, Issue:3

    Topics: Administration, Oral; Aged; Benserazide; Bromocriptine; Deglutition; Deglutition Disorders; Drug Administration Schedule; Eating; Humans; Levodopa; Male; Parkinson Disease

1995
Effect of disease and drug treatment on blood serotonin and monoamine oxidase B activity in Parkinson's disease.
    Clinical neurology and neurosurgery, 1995, Volume: 97, Issue:2

    Topics: Adult; Aged; Amantadine; Blood Platelets; Bromocriptine; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Monoamine Oxidase; Parkinson Disease; Selegiline; Serotonin; Treatment Outcome

1995
Medullary thyroid carcinoma.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Adrenal Gland Neoplasms; Antineoplastic Agents; Bromocriptine; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Levodopa; Lymph Node Excision; Lymphatic Metastasis; Neoplasm Metastasis; Neoplasm Staging; Octreotide; Pheochromocytoma; Recurrence; Survival Rate; Thyroid Neoplasms; Thyroidectomy

1994
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats.
    Journal of neural transmission. General section, 1994, Volume: 98, Issue:1

    Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline

1994
Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile.
    Annals of neurology, 1995, Volume: 37, Issue:1

    Topics: Aged; Bromocriptine; Cabergoline; Chorea; Dopamine Agonists; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Monitoring, Physiologic; Parkinson Disease; Pergolide; Sweating

1995
Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro.
    Brain research, 1994, Sep-19, Volume: 657, Issue:1-2

    Topics: Animals; Bromocriptine; Carbidopa; Corpus Striatum; Desipramine; Dopamine; Free Radical Scavengers; Hydroxyl Radical; Injections, Intraventricular; Levodopa; Male; Mice; Mice, Inbred ICR; Oxidopamine

1994
Seven-year follow-up study of bromocriptine therapy for Parkinson's disease.
    European neurology, 1994, Volume: 34 Suppl 3

    Topics: Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Neurologic Examination; Neurons; Parkinson Disease; Substantia Nigra

1994
Day-night variation of urine volume in Parkinson's disease.
    The Japanese journal of psychiatry and neurology, 1994, Volume: 48, Issue:3

    Topics: Adult; Aged; Amantadine; Bromocriptine; Circadian Rhythm; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors; Trihexyphenidyl; Urine

1994
[Bromocriptine-induced pleuropneumopathy].
    Deutsche medizinische Wochenschrift (1946), 1994, Nov-11, Volume: 119, Issue:45

    Topics: Benserazide; Biperiden; Bromocriptine; Humans; Levodopa; Lung Diseases; Male; Middle Aged; Parkinson Disease; Pleural Effusion; Pulmonary Atelectasis; Pulmonary Fibrosis; Radiography; Selegiline; Time Factors

1994
Management of neuroleptic malignant syndrome--a series of eight cases.
    The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:2

    Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome

1993
[Diagnosis and treatment of Parkinson's disease in the elderly].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1993, Volume: 30, Issue:12

    Topics: Aged; Brain; Bromocriptine; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sulpiride; Tiapamil Hydrochloride

1993
Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment.
    Movement disorders : official journal of the Movement Disorder Society, 1994, Volume: 9, Issue:2

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Chorea; Circadian Rhythm; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Levodopa; Male; Middle Aged; Neurologic Examination; Parkinson Disease

1994
Dopaminergic hallucinosis with fluoxetine in Parkinson's disease.
    The American journal of psychiatry, 1993, Volume: 150, Issue:11

    Topics: Aged; Bromocriptine; Carbidopa; Fluoxetine; Hallucinations; Humans; Levodopa; Male; Parkinson Disease; Visual Perception

1993
Short-term memory and temporal ordering in early Parkinson's disease: effects of disease chronicity and medication.
    Neuropsychologia, 1993, Volume: 31, Issue:9

    Topics: Adult; Aged; Brain; Bromocriptine; Dementia; Female; Frontal Lobe; Humans; Language Tests; Levodopa; Male; Memory Disorders; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Parasympatholytics; Parkinson Disease; Psychiatric Status Rating Scales; Reaction Time; Task Performance and Analysis

1993
Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations.
    Annals of neurology, 1993, Volume: 34, Issue:5

    Topics: Aged; Bromocriptine; Carbidopa; Hallucinations; Humans; Levodopa; Parkinson Disease; Pergolide; Polysomnography; Sleep; Sleep, REM

1993
Combination therapy for PD.
    Neurology, 1993, Volume: 43, Issue:12

    Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Parkinson Disease; Randomized Controlled Trials as Topic

1993
Combination therapy for PD.
    Neurology, 1993, Volume: 43, Issue:12

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic

1993
Event-related potentials in Parkinson's disease: a 12-month follow-up study.
    Journal of the neurological sciences, 1993, Volume: 116, Issue:2

    Topics: Adult; Aged; Bromocriptine; Cognition; Drug Therapy, Combination; Evoked Potentials, Auditory; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies

1993
Parkinson's disease study.
    European journal of clinical pharmacology, 1993, Volume: 44, Issue:6

    Topics: Benserazide; Bias; Bromocriptine; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease

1993
Amantadine withdrawal and neuroleptic malignant syndrome.
    Neurology, 1993, Volume: 43, Issue:10

    Topics: Amantadine; Bromocriptine; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

1993
Aromatic L-amino acid decarboxylase activity of mouse striatum is modulated via dopamine receptors.
    Journal of neurochemistry, 1993, Volume: 60, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Bromocriptine; Corpus Striatum; Cycloheximide; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Pyridoxal Phosphate; Receptors, Dopamine; Reserpine; Sulpiride; Time Factors

1993
Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats.
    Brain research, 1993, Apr-16, Volume: 608, Issue:2

    Topics: Acetylcholine; Animals; Bromocriptine; Corpus Striatum; Dialysis; Levodopa; Male; Oxidopamine; Rats; Rats, Wistar

1993
Locally formed dopamine modulates renal Na-Pi co-transport through DA1 and DA2 receptors.
    The Biochemical journal, 1995, Dec-01, Volume: 312 ( Pt 2)

    Topics: Adenylate Cyclase Toxin; Animals; Benserazide; Bromocriptine; Calcium; Carbidopa; Carrier Proteins; Cell Line; Cyclic AMP; Dopamine; Kidney Tubules, Proximal; Kinetics; Levodopa; Opossums; Parathyroid Hormone; Pertussis Toxin; Phosphates; Receptors, Dopamine D1; Receptors, Dopamine D2; Sodium; Sodium-Phosphate Cotransporter Proteins; Symporters; Virulence Factors, Bordetella

1995
Levodopoa but not bromocriptine induces AP-1 and creb DNA-binding activity in the dopamine-depleted striatum of the rat.
    Life sciences, 1996, Volume: 58, Issue:10

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Base Sequence; Behavior, Animal; Bromocriptine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Dopamine; Dopamine Agonists; Levodopa; Male; Molecular Sequence Data; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Transcription Factor AP-1

1996
Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients.
    Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:3

    Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Dominance, Cerebral; Electric Stimulation Therapy; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Motor Skills; Neurologic Examination; Parkinson Disease; Thalamic Nuclei; Treatment Outcome

1996
Levodopa induces AP-1 and CREB DNA-binding activities in the rat striatum.
    Psychiatry and clinical neurosciences, 1995, Volume: 49, Issue:5-6

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; CREB-Binding Protein; DNA-Binding Proteins; Dose-Response Relationship, Drug; Gene Expression; Levodopa; Male; Nuclear Proteins; Proto-Oncogene Proteins c-jun; Rats; Rats, Sprague-Dawley; Trans-Activators; Transcription Factor AP-1; Transcription Factors

1995
Plasma levels of the beta-carbolines harman and norharman in Parkinson's disease.
    Acta neurologica Scandinavica, 1995, Volume: 92, Issue:6

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbolines; Female; Humans; Levodopa; Male; Middle Aged; Mitochondria; Parkinson Disease; Selegiline

1995
Effects of bromocriptine and/or L-DOPA on neurons in substantia nigra of MPTP-treated C57BL/6 mice.
    Brain research, 1996, Jul-29, Volume: 728, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Bromocriptine; Cell Count; Levodopa; Mice; Mice, Inbred C57BL; Substantia Nigra

1996
Postencephalitic stereotyped involuntary movements responsive to L-Dopa.
    Movement disorders : official journal of the Movement Disorder Society, 1996, Volume: 11, Issue:5

    Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Encephalitis; Humans; Levodopa; Magnetic Resonance Imaging; Male; Parkinson Disease, Secondary; Putamen; Receptors, Dopamine D2; Stereotyped Behavior; Tomography, X-Ray Computed; Trihexyphenidyl

1996
[Malignant-like neuroleptic syndrome: a sign to call attention to].
    Anales de medicina interna (Madrid, Spain : 1984), 1995, Volume: 12, Issue:9

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Cephalosporins; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease

1995
Drug-induced hyperthermia in a patient with persistent vegetative state. Case report and review of the literature.
    Journal of neurosurgical sciences, 1995, Volume: 39, Issue:3

    Topics: Adult; Body Temperature; Bromocriptine; Fever; Follow-Up Studies; Humans; Levodopa; Male; Time Factors

1995
Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
    European journal of pharmacology, 1997, Jan-29, Volume: 319, Issue:2-3

    Topics: Administration, Oral; Adrenergic alpha-Agonists; Animals; Azepines; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Hypnotics and Sedatives; Injections, Subcutaneous; Levodopa; Macaca fascicularis; Male; Receptors, Dopamine D2; Tegmentum Mesencephali; Tremor

1997
Analyzer workshop on the treatment of Parkinson's disease.
    European neurology, 1997, Volume: 38 Suppl 1

    Topics: Adult; Antiparkinson Agents; Bromocriptine; Cerebrovascular Disorders; Computer Simulation; Diagnosis, Differential; Forecasting; Humans; Levodopa; Middle Aged; Parkinson Disease; Supranuclear Palsy, Progressive; Tablets

1997
[A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
    Revista de neurologia, 1997, Volume: 25, Issue:145

    Topics: Aged; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Pergolide; Retrospective Studies; Tremor

1997
Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice.
    Life sciences, 1997, Volume: 61, Issue:26

    Topics: Animals; Bromocriptine; Carbidopa; Catalepsy; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Kinetics; Levodopa; Male; Mice; Motor Activity

1997
De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset.
    Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Indoles; Levodopa; Male; Motor Skills; Neurologic Examination; Parkinson Disease, Secondary; Receptors, Dopamine D2

1998
Monitoring randomised controlled trials. Parkinson's disease trial illustrates the dangers of stopping early.
    BMJ (Clinical research ed.), 1998, Apr-18, Volume: 316, Issue:7139

    Topics: Antiparkinson Agents; Bromocriptine; Decision Making; Humans; Levodopa; Parkinson Disease; Randomized Controlled Trials as Topic; Selegiline

1998
Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Experimental neurology, 1998, Volume: 151, Issue:2

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Clonidine; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Levodopa; Lisuride; Locomotion; Male; Mazindol; Methoxydimethyltryptamines; Oxidopamine; Parkinson Disease, Secondary; Prosencephalon; Rats; Rats, Sprague-Dawley; Sympatholytics; Tritium; Yohimbine

1998
Magnetic resonance imaging and 11C-N-methylspiperone/positron emission tomography studies in a patient with the interval form of carbon monoxide poisoning.
    Journal of the neurological sciences, 1998, Sep-18, Volume: 160, Issue:1

    Topics: Basal Ganglia; Bromocriptine; Carbon Monoxide Poisoning; Carbon Radioisotopes; Caudate Nucleus; Cerebral Hemorrhage; Combined Modality Therapy; Convalescence; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Globus Pallidus; Humans; Hyperbaric Oxygenation; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Nerve Tissue Proteins; Parkinson Disease, Secondary; Psychomotor Performance; Putamen; Receptors, Dopamine D2; Spiperone; Tomography, Emission-Computed

1998
Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Experimental neurology, 1999, Volume: 155, Issue:2

    Topics: Animals; Autoradiography; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Enkephalins; In Situ Hybridization; Levodopa; Lisuride; Male; Mazindol; Medial Forebrain Bundle; Neostriatum; Oligonucleotide Probes; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Radioligand Assay; Rats; Rats, Sprague-Dawley; RNA, Messenger

1999
Ropinirole: new preparation. Wait for more convincing data.
    Prescrire international, 1998, Volume: 7, Issue:34

    Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; France; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Time Factors; Treatment Outcome

1998
Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:3

    Topics: Adult; Antiparkinson Agents; Brain Edema; Bromocriptine; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Magnetic Resonance Imaging; Male; Methanol; Parkinson Disease, Secondary; Putamen; Tomography, X-Ray Computed

1999
Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
    Experimental neurology, 1999, Volume: 159, Issue:1

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Antisense Elements (Genetics); Autoreceptors; Bromocriptine; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Fetus; Fluoresceins; Free Radicals; Gene Expression; Levodopa; Mesencephalon; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Tyrosine 3-Monooxygenase

1999
Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data.
    Journal of the neurological sciences, 1999, Nov-30, Volume: 170, Issue:2

    Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Disease Progression; Erythrocytes; Humans; Hydroxyl Radical; Levodopa; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pergolide; Severity of Illness Index; Statistics as Topic; Superoxide Dismutase; Time Factors

1999
Influence of dopaminergic anti-Parkinsonian agents on inflammatory reactions in rats.
    Die Pharmazie, 2000, Volume: 55, Issue:6

    Topics: Animals; Antiparkinson Agents; Arthritis, Experimental; Benserazide; Bromocriptine; Carrageenan; Dopamine Agents; Edema; Evans Blue; Female; Inflammation; Levodopa; Rats; Rats, Wistar

2000
Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum.
    Neurochemical research, 2000, Volume: 25, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bromocriptine; Corpus Striatum; Dopamine; Homovanillic Acid; Levodopa; Male; Parkinson Disease; Rats; Rats, Sprague-Dawley

2000
Influence of dopamine energic pharmacology drugs on secretion of the adrenocorticotropic hormone from the hypophysis.
    Microbios, 2000, Volume: 102, Issue:403

    Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Carbidopa; Dopamine; Dopamine Agents; Drug Therapy, Combination; Levodopa; Male; Pituitary Gland; Rats; Rats, Wistar

2000
Effects of ropinirole on motor behavior in MPTP-treated common marmosets.
    Pharmacology, biochemistry, and behavior, 2000, Volume: 67, Issue:1

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Agonists; Female; Indoles; Levodopa; Male; Motor Activity; MPTP Poisoning; Receptors, Dopamine D2; Receptors, Dopamine D3

2000
[Dopaminergic agonists in the treatment of Parkinson's disease].
    Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6

    Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles

2000
Neuroleptic malignant syndrome without neuroleptics.
    Singapore medical journal, 2001, Volume: 42, Issue:2

    Topics: Antiparkinson Agents; Bromocriptine; Creatine Kinase; Diagnosis, Differential; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Levodopa; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome

2001
Pergolide and Parkinson's disease: new preparation. No clear benefit.
    Prescrire international, 2000, Volume: 9, Issue:50

    Topics: Antiparkinson Agents; Bromocriptine; Clinical Trials as Topic; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Parkinson Disease; Pergolide; Treatment Outcome

2000
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1

    Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome

2001
Randomized clinical trials with added rescue medication: some approaches to their analysis and interpretation.
    Statistics in medicine, 2001, Oct-30, Volume: 20, Issue:20

    Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Humans; Indoles; Levodopa; Multicenter Studies as Topic; Parkinson Disease; Randomized Controlled Trials as Topic; Regression Analysis; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome

2001
Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease.
    The European journal of neuroscience, 2001, Volume: 14, Issue:7

    Topics: Animals; Bromocriptine; Denervation; Disease Models, Animal; Dopamine Agents; Dopamine Agonists; Drug Administration Schedule; Enkephalins; Female; Gene Expression Regulation; Immunohistochemistry; Levodopa; Neostriatum; Oxidopamine; Parkinsonian Disorders; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympatholytics

2001
Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 300, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; alpha-Synuclein; Animals; Animals, Genetically Modified; Antiparkinson Agents; Bromocriptine; Disease Models, Animal; Drosophila melanogaster; Genotype; Levodopa; Motor Activity; Nerve Tissue Proteins; Neurons; Parkinson Disease; Pergolide; Postural Balance; Synapses; Synucleins

2002
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.
    The European journal of neuroscience, 2002, Volume: 15, Issue:1

    Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Behavior, Animal; Bromocriptine; Dyskinesia, Drug-Induced; Female; Gait; Levodopa; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Rotation; Stereotyped Behavior; Sympatholytics

2002
Dopamine replacement therapy reverses abnormal synchronization of pallidal neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of parkinsonism.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002, Sep-15, Volume: 22, Issue:18

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Antiparkinson Agents; Bromocriptine; Carbidopa; Chlorocebus aethiops; Disease Models, Animal; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Electrodes, Implanted; Female; Globus Pallidus; Levodopa; Neurons; Organic Chemicals; Parkinsonian Disorders

2002
Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.
    Neuroscience, 2002, Volume: 115, Issue:4

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Callithrix; Dopamine Uptake Inhibitors; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Male; Mazindol; Neostriatum; Neural Pathways; Neuropeptides; Parkinsonian Disorders; Protein Precursors; Receptors, Purinergic P1; RNA, Messenger; Tachykinins

2002
Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease A short commentary.
    Journal of neurology, 2003, Volume: 250, Issue:1

    Topics: Antiparkinson Agents; Bromocriptine; Drug Therapy, Combination; Humans; Indoles; Levodopa; Parkinson Disease

2003
Levodopa and bromocriptine in hypoxic brain injury.
    Journal of neurology, 2002, Volume: 249, Issue:12

    Topics: Adult; Bromocriptine; Drug Therapy, Combination; Female; Humans; Hypoxia, Brain; Levodopa; Male; Middle Aged; Radiography; Tomography, Emission-Computed, Single-Photon

2002
The prevalence of Parkinson's disease in British Columbia, Canada, estimated by using drug tracer methodology.
    Parkinsonism & related disorders, 2003, Volume: 9, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; British Columbia; Bromocriptine; Data Interpretation, Statistical; Databases, Factual; Drug Prescriptions; Drug Utilization; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Sex Factors

2003
[Sexual delinquency and Parkinson's disease].
    Der Nervenarzt, 2003, Volume: 74, Issue:4

    Topics: Antiparkinson Agents; Awareness; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Exhibitionism; Expert Testimony; Humans; Impulsive Behavior; Indoles; Levodopa; Libido; Male; Middle Aged; Parkinson Disease; Pedophilia; Sex Offenses

2003
The use of dopamine enhancing medications with children in low response states following brain injury.
    Brain injury, 2003, Volume: 17, Issue:6

    Topics: Adolescent; Adult; Amantadine; Arousal; Awareness; Benzothiazoles; Brain Injuries; Bromocriptine; Child; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Methylphenidate; Neuropsychological Tests; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome; Unconsciousness

2003
[Therapy for patients with early-stage Parkinson's disease].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2003, Aug-10, Volume: 92, Issue:8

    Topics: Amantadine; Animals; Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Practice Guidelines as Topic; Selegiline; Trihexyphenidyl

2003
[Ludopathy induced by levodopa associated with bromocriptin].
    Presse medicale (Paris, France : 1983), 2003, Aug-09, Volume: 32, Issue:26

    Topics: Bromocriptine; Dopamine Agents; Drug Interactions; Female; Gambling; Humans; Levodopa; Middle Aged

2003
[Two cases of Parkinson's disease in which visual hallucinations disappeared after cataract surgery].
    No to shinkei = Brain and nerve, 2004, Volume: 56, Issue:4

    Topics: Aged; Antiparkinson Agents; Bromocriptine; Cataract Extraction; Female; Hallucinations; Humans; Levodopa; Parkinson Disease; Remission Induction; Risperidone; Visual Perception

2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles

2004
Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:2

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Bromocriptine; Dementia; Disease Progression; Dose-Response Relationship, Drug; Employment; Female; Follow-Up Studies; Humans; Levodopa; Male; Middle Aged; Mortality; Movement Disorders; Multicenter Studies as Topic; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Time Factors

2005
Analysis of the course of Parkinson's disease under dopaminergic therapy: performance of "fast tapping" is not a suitable parameter.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:3

    Topics: Bromocriptine; Cross-Sectional Studies; Disease Progression; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

2005
Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice.
    Neuroscience research, 2005, Volume: 51, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Behavior, Animal; Blotting, Western; Brain Chemistry; Bromocriptine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Drug Interactions; Hindlimb Suspension; Immobility Response, Tonic; Immunohistochemistry; Levodopa; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Nerve Tissue Proteins; Selegiline; Time Factors; Tyrosine 3-Monooxygenase

2005
A proposed mechanism for diurnal/nocturnal bruxism: hypersensitivity of presynaptic dopamine receptors in the frontal lobe.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2005, Volume: 12, Issue:2

    Topics: Aged; Bromocriptine; Bruxism; Dopamine Agents; Female; Frontal Lobe; Humans; Levodopa; Male; Metoclopramide; Receptors, Dopamine; Sleep Bruxism

2005
Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
    Prescrire international, 2005, Volume: 14, Issue:76

    Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Dyskinesias; France; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease

2005
Bromocriptine in traumatic brain injury.
    Brain injury, 2006, Volume: 20, Issue:1

    Topics: Brain Injuries; Bromocriptine; Cognition; Dopamine Agonists; Head Injuries, Closed; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychomotor Performance

2006
Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
    Parkinsonism & related disorders, 2006, Volume: 12, Issue:5

    Topics: Aged; Antiparkinson Agents; Autonomic Nervous System; Bromocriptine; Disability Evaluation; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Levodopa; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Pergolide; Prognosis; Survival Analysis

2006
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatments.
    Journal of pharmacokinetics and pharmacodynamics, 2006, Volume: 33, Issue:3

    Topics: Algorithms; Antiparkinson Agents; Bayes Theorem; Bromocriptine; Disease Progression; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Models, Biological; Parkinson Disease; Pergolide; Randomized Controlled Trials as Topic; Selegiline; Treatment Outcome

2006
Changes in gait and symptoms after bilateral pallidotomy: a client with Parkinson's disease.
    Physiotherapy research international : the journal for researchers and clinicians in physical therapy, 2006, Volume: 11, Issue:3

    Topics: Antiparkinson Agents; Bromocriptine; Combined Modality Therapy; Disease Progression; Female; Gait; Globus Pallidus; Humans; Levodopa; Middle Aged; Pallidotomy; Parkinson Disease; Severity of Illness Index; Time Factors; Treatment Outcome

2006
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with L-DOPA: relation to dose and route of administration.
    Behavioural brain research, 2007, Feb-12, Volume: 177, Issue:1

    Topics: Analysis of Variance; Animals; Brain Injuries; Bromocriptine; Cell Count; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Immunohistochemistry; Levodopa; Lipopolysaccharides; Movement Disorders; Oxidopamine; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Time Factors; Tyrosine 3-Monooxygenase

2007
[Juvenile Parkinson's disease and recurring prematurity. Case report].
    Gynecologie, obstetrique & fertilite, 2007, Volume: 35, Issue:3

    Topics: Adult; Antiparkinson Agents; Bromocriptine; Female; Humans; Infant, Newborn; Infant, Premature; Levodopa; Obstetric Labor, Premature; Parkinsonian Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome

2007
Short episode of seizures in a newborn of a mother treated with levodopa/carbidopa/entacapone and bromocriptine.
    Movement disorders : official journal of the Movement Disorder Society, 2007, Jul-30, Volume: 22, Issue:10

    Topics: Adolescent; Antiparkinson Agents; Bromocriptine; Catechols; Drug Therapy, Combination; Epilepsy; Female; Humans; Levodopa; Nitriles; Parkinson Disease; Pregnancy; Prenatal Exposure Delayed Effects

2007
Agonist or levodopa for Parkinson disease? Ultimately, it doesn't matter; neither is good enough.
    Neurology, 2009, Jun-16, Volume: 72, Issue:24

    Topics: Bromocriptine; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Follow-Up Studies; Humans; Indoles; Levodopa; Parkinson Disease; Practice Patterns, Physicians'; Prevalence; Randomized Controlled Trials as Topic; Time; Treatment Outcome

2009
Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:12

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aminoacetonitrile; Animals; Antiparkinson Agents; Basal Ganglia; Benzazepines; Bromocriptine; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Extracellular Signal-Regulated MAP Kinases; Female; Levodopa; Neovascularization, Pathologic; Oxidopamine; Parkinsonian Disorders; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides

2009
Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding.
    Synapse (New York, N.Y.), 2010, Volume: 64, Issue:8

    Topics: Animals; Binding, Competitive; Brain; Brain Chemistry; Bromocriptine; Cannabinoid Receptor Modulators; CHO Cells; Cricetinae; Cricetulus; Drug Administration Schedule; Female; Levodopa; Positron-Emission Tomography; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Up-Regulation

2010
Pre-treatment with dopamine agonists influence L-dopa mediated rotations without affecting abnormal involuntary movements in the 6-OHDA lesioned rat.
    Behavioural brain research, 2010, Nov-12, Volume: 213, Issue:1

    Topics: Animals; Antiparkinson Agents; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dyskinesia, Drug-Induced; Enkephalins; Female; Indoles; Levodopa; Oxidopamine; Parkinsonian Disorders; Piribedil; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotation; Time Factors

2010
[General anaesthesia for neurological diseases].
    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 2010, Volume: 45, Issue:5

    Topics: Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Autonomic Nervous System; Brain; Bromocriptine; Dopamine Agonists; Humans; Intubation; Levodopa; Monoamine Oxidase Inhibitors; Muscle Relaxants, Central; Nervous System Diseases; Neurodegenerative Diseases; Neurosurgery; Parkinson Disease; Piperidines; Premedication; Preoperative Care; Propofol; Remifentanil; Selegiline; Stereotaxic Techniques; Syndrome

2010
Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study).
    Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:9

    Topics: Age Factors; Age of Onset; Aged; Antiparkinson Agents; Bromocriptine; Cognition; Cohort Studies; Dementia; Disease Progression; Female; Humans; Levodopa; Longitudinal Studies; Male; Memory; Middle Aged; Neurologic Examination; Neuropsychological Tests; New South Wales; Parkinson Disease; Survival Analysis

2011
Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist.
    Parkinsonism & related disorders, 2011, Volume: 17, Issue:8

    Topics: Aged; Antiparkinson Agents; Asian People; Bromocriptine; China; Cross-Sectional Studies; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Drug Therapy, Combination; Ergot Alkaloids; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies

2011
Combined low calcium and lack magnesium is a risk factor for motor deficit in mice.
    Bioscience, biotechnology, and biochemistry, 2013, Volume: 77, Issue:2

    Topics: Amantadine; Animals; Antiparkinson Agents; Benserazide; Bromocriptine; Calcium; Catalepsy; Dopamine Agonists; Food, Formulated; Levodopa; Magnesium; Magnesium Deficiency; Male; Mice; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Substantia Nigra; Tyrosine 3-Monooxygenase

2013
Occlusal treatment with bite splint improves dyskinesia in Parkinson's disease patient: a case report.
    The Bulletin of Tokyo Dental College, 2013, Volume: 54, Issue:3

    Topics: Activities of Daily Living; Antiparkinson Agents; Bromocriptine; Cabergoline; Clonidine; Dyskinesias; Ergolines; Female; Hand Strength; Humans; Levodopa; Middle Aged; Motor Skills; Occlusal Splints; Parkinson Disease; Posture

2013
Alteration in the expression of exon IIC transcripts of brain-derived neurotrophic factor gene by simvastatin [correction of simvastain] in chronic mild stress in mice: a possible link with dopaminergic pathway.
    Canadian journal of physiology and pharmacology, 2014, Volume: 92, Issue:12

    Topics: Animals; Brain-Derived Neurotrophic Factor; Bromocriptine; Chronic Disease; Dopamine; Dopamine Agents; Eating; Exons; Haloperidol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Levodopa; Lipid Metabolism; Male; Mice; Signal Transduction; Simvastatin; Stress, Psychological; Sucrose; Transcription, Genetic

2014
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.
    Journal of neural transmission (Vienna, Austria : 1996), 2017, Volume: 124, Issue:1

    Topics: Animals; Antiparkinson Agents; Biosensing Techniques; Bromocriptine; Catecholamines; Dopamine Agonists; Dopaminergic Neurons; Equipment Design; Levodopa; Mice; Molecular Imaging; Nanotechnology; Neuroimaging; Parkinson Disease; Precision Medicine; Substantia Nigra

2017
Dopamine D
    Psychoneuroendocrinology, 2020, Volume: 113

    Topics: Animals; Blood Glucose; Bromocriptine; Circadian Rhythm; Diabetes Mellitus, Type 2; Dopamine; Dopamine Agonists; Female; Glucose; Insulin; Insulin-Secreting Cells; Levodopa; Mice; Mice, Inbred C57BL; Obesity; Receptors, Dopamine D2; Sulpiride; Weight Gain

2020
D
    European journal of pharmacology, 2021, Feb-05, Volume: 892

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Brain; Bromocriptine; Chlorocebus aethiops; Disease Models, Animal; Dopamine Agonists; Levodopa; Male; Motor Activity; Parkinsonian Disorders; Phenanthridines; Receptors, Dopamine D1; Receptors, Dopamine D2

2021